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Abstract
Chapter 1: Since the early 2000s, evidence has accumulated for a significant differential ef-
fect of first-line antiretroviral therapy (ART) regimens on human immunodeficiency virus (HIV)
treatment outcomes, such as CD4 response and viral load suppression. This finding was replicated
in our data from the Harvard President’s Emergency Plan for AIDS Relief (PEPFAR) program in
Nigeria. Investigators were interested in finding the source of these differences, i.e., understanding
the mechanisms through which one regimen outperforms another, particularly via adherence. This
amounts to a mediation question with adherence playing the role of mediator. Existing mediation
analysis results, however, have relied on an assumption of no exposure-induced confounding of
the intermediate variable, and generally require an assumption of no unmeasured confounding for
nonparametric identification. Both assumptions are violated by the presence of drug toxicity. In
this paper, we relax these assumptions and show that certain path-specific effects remain identi-
fied under weaker conditions. We focus on the path-specific effect solely mediated by adherence
and not by toxicity and propose a suite of estimators for this effect, including a semiparametric-
efficient, multiply-robust estimator. We illustrate with simulations and present results from a study
applying the methodology to the Harvard PEPFAR data.
Chapter 2: In causal mediation analysis, nonparametric identification of the pure (natural) di-
rect effect typically relies on fundamental assumptions of (i) so-called “cross-world-counterfactuals"
independence and (ii) no exposure-induced confounding. When the mediator is binary, bounds for
partial identification have been given when neither assumption is made, or alternatively when as-
suming only (ii). We extend these bounds to the case of a polytomous mediator, and provide
bounds for the case assuming only (i). We apply these bounds to data from the Harvard PEPFAR
program in Nigeria, where we evaluate the extent to which the effects of antiretroviral therapy on
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virological failure are mediated by a patient’s adherence, and show that inference on this effect is
somewhat sensitive to model assumptions.
Chapter 3: When assessing the presence of an exposure causal effect on a given outcome, it is
well known that classical measurement error of the exposure can seriously reduce the power of a
test of the null hypothesis in question, although its type I error rate will generally remain controlled
at the nominal level. In contrast, classical measurement error of a confounder can have disastrous
consequences on the type I error rate of a test of treatment effect. In this paper, we develop a large
class of semiparametric test statistics of an exposure causal effect, which are completely robust to
classical measurement error of a subset of confounders. A unique and appealing feature of our pro-
posed methods is that they require no external information such as validation data or replicates of
error-prone confounders. The approach relies on the observation that under the sharp null hypoth-
esis of no exposure causal effect, the standard assumption of no unmeasured confounding implies
that the outcome is in fact a valid instrumental variable for the association between the error-prone
confounder and the exposure. We present a doubly-robust form of this test that requires only one
of two models – an outcome-regression and a propensity-score model – to be correctly specified
for the resulting test statistic to have correct type I error rate. Validity and power within our class
of test statistics is demonstrated via multiple simulation studies. We apply the methods to a multi-
U.S.-city, time-series data set to test for an effect of temperature on mortality while adjusting for
atmospheric particulate matter with diameter of 2.5 micrometres or less (PM2.5), which is well
known to be measured with error.
iv
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Quantifying an Adherence Path-Specific Effect of
Antiretroviral Therapy in the Nigeria PEPFAR Program
Caleb H. Miles, Ilya Shpitser, Phyllis Kanki, Seema Meloni, and Eric J. Tchetgen
Tchetgen
Department of Biostatistics
Harvard School of Public Health
1.1 Introduction
The President’s Emergency Plan for AIDS Relief (PEPFAR) has been a highly successful program
that has saved millions of lives worldwide since its inception in 2003. The Harvard School of
Public Health was awarded one of the PEPFAR grants, receiving a total of $362 million for work
in Nigeria, Botswana, and Tanzania. The program has furnished these countries with invaluable
medical infrastructure and supported AIDS care services in Nigeria for over 160,000 people and
treatment to approximately 105,000 of those patients.
Our data set consists of previously antiretroviral therapy (ART)-naïve, human immunodefi-
ciency virus (HIV)-1 infected, adult patients enrolled in the Harvard PEPFAR/AIDS Prevention
Initiative in Nigeria (APIN) program between June 2004 and November 2010 who started ART
in the program and were followed for at least 1 year after initiating ART. Upon entry into the
Harvard/APIN PEPFAR HIV care program, all patients completed informed consent; all consent
forms were approved by the institutional review boards at Harvard, APIN and all the corresponding
Harvard/APIN PEPFAR HIV care and treatment sites. Patients not on one of 6 standard first-line
regimens at baseline or seen at two of the hospitals without reliable viral load data were excluded
from the data set. The analysis in this paper consists of only the complete cases, and results are
given for all regimens but d4T+3TC+EFV (see Table 1.1 note for full drug names), due to the small
sample of patients on this regimen as a consequence of it having been dropped midway through the
program. d4T+3TC+NVP was also dropped, but had a large enough sample to provide for stable
inference.
The significant funding support for AIDS treatment in resource-limited settings provided by
PEPFAR and other international donor organizations relied on clinical trial data generated in re-
source rich settings. In order to maximize the benefit of providing ART to the largest number of
patients, well-established drug regimens that were less costly were recommended and supported by
the program. Studies dating back to the early 2000s have demonstrated evidence that these first-line
regimens were not equally effective (Tang et al., 2012), and indeed, in the Harvard PEPFAR data,
we have observed a significant differential effect of first-line ART regimens on virologic failure
and, to a lesser extent, CD4 count. Since these were first-line regimens in use in most resource-
limited settings, this difference could have widespread implications to the success of ART pro-
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Table 1.1: Treatment regimen coding and their estimated average causal effects on risk of virologic
failure (VF) and CD4 count
Patients on RR of log-RR of Mean diff. in
Code ART regimen regimen VF (s.e.) VF (s.e.) CD4 count
1 TDF + 3TC/FTC + EFV 1448 (14.6%) 0.65 (0.014) -0.44 (0.12) 6.9 (7.4)
2 d4T + 3TC + NVP 854 (8.6%) 0.75 (0.017) -0.29 (0.13) -9.7 (6.8)
3 AZT + 3TC + EFV 1003 (10.1%) 0.78 (0.018) -0.25 (0.14) 10.7 (8.7)
4 AZT + 3TC + NVP 4707 (47.4%) 0.82 (0.011) -0.21 (0.078) 17.8 (4.9)
5 TDF + 3TC/FTC + NVP 1919 (19.3%) - - -
NOTE: 3TC=lamivudine, AZT=zidovudine, d4T=stavudine, EFV=efavirenz, FTC=emtricitabine,
NVP=nevirapine, TDF=tenofovir. Effects on risk of virologic failure are expressed on the risk ratio
(RR) and log-risk ratio scale relative to treatment 5 and were estimated using inverse-probability
weighted estimators. Effects on CD4 count are expressed on the mean difference scale relative
to treatment 5 and were estimated using doubly-robust estimators. All effects adjusted for the
confounders listed in Section 1.2.
grams. These regimens and each of their corresponding total effects on virologic failure and CD4
count relative to a common reference treatment are reported in Table 1.1. The effects on virologic
failure are reported as marginal and log-marginal risk ratios, and the effects on CD4 count and
log CD4 count are reported on the mean-difference scale. Treatments were coded from strongest
estimated effect on virologic failure to weakest, and the weakest treatment (TDF+3TC/FTC+NVP)
was chosen as the reference for the purposes of the effects in Table 1.1. These effects are contrasts
in the population between the risk of virologic failure had one intervened to assign everyone to
a comparison-level treatment (1, 2, 3, or 4) and that if one had intervened to assign everyone to
baseline treatment 5. The total effects of these regimens, however, do not quite tell the whole
story. Investigators were interested in finding the source of these differences, i.e., understanding
the mechanisms through which one regimen outperforms another. Mediation analysis serves to
better explain these mechanisms that drive the differences in effects. This type of analysis has the
potential to help target interventions to improve the performance of the less-robust regimens.
The total effect can be considered as a combination of effects, possibly in conflicting direc-
tions, through different pathways from the exposure to the outcome. Therefore, a weak total effect
could be due to a combination of even weaker path-specific effects or several stronger path-specific
effects canceling one another out. One such path-specific effect could work strictly through biolog-
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ical pathways, in which case this population would benefit most from switching to a more favorable
drug regimen. Alternatively, biological factors might play a comparatively smaller role relative to
the effect of the treatment through nonbiological pathways, such as through adherence (Shpitser,
2013). We suspect a lack of adherence to treatment to be a driving mechanism of the observed
differential effects, in which case it would be worth considering how to improve this mediating
factor.
Adherence is widely accepted as a key factor for sustained viral suppression and is consid-
ered a prerequisite for maintenance on a prescribed drug regimen and optimal patient outcomes.
However, the extent to which adherence to a given choice of first-line ART contributes to virologic
failure (defined by the World Health Organization [WHO] as repeat viral load > 1000 copies/mL
after 6 months of ART duration) is complex and still poorly understood and is a pressing mediation
question in HIV research (Bangsberg et al., 2000). Understanding this issue is particularly impor-
tant in resource-limited settings, where ART regimen options are few, and adherence to lifelong
multi-drug daily dosing is challenging, but necessary. In such settings, quantifying to what degree
differential rates of virologic failure are due to differences in adherence rates between therapies
would inform the extent to which failure rates could be reduced by programs that improve adher-
ence rates for certain ARTs, rather than changing the ART regimens themselves. Such adherence
interventions have been very successful in the treatment of tuberculosis (China Tuberculosis Con-
trol Collaboration, 1996; Fujiwara et al., 1997; Suárez et al., 2001) and are considered similarly
important in the treatment of HIV (Mills et al., 2006; Vranceanu et al., 2008; Pop-Eleches et al.,
2011).
Remark. Technically, the WHO also requires demonstration of adherence in their definition of
virologic failure, which we avoid using in this paper since we cannot study the role of adherence
as a mediator when it is part of the definition of the outcome.
Among other potential mechanisms, the effect of treatment on virologic failure and CD4 count
may be mediated by adherence, drug toxicity, or both. This study investigates the extent to which
adherence, and not drug toxicity, mediates the effect, using the Harvard PEPFAR data set. That
is, we focus on the role of adherence when it is differentially affected by the ways the drugs
are obtained and taken, rather than by different levels of toxic side effects. The effect mediated
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by nonadherence due to toxicity is unlikely to be appreciable, since toxicity in Nigeria is typically
clinically recognizable and actionable. The magnitude of the roles of other drug-specific predictors
of nonadherence, on the other hand, are less understood. These predictors also potentially point to
lower-hanging fruit for development of adherence-promoting interventions. In mediation analysis
terminology, we aim to estimate the effects of treatment assignment on virologic failure and CD4
count that are indirect with respect to adherence but direct with respect to toxicity. The definition,
identification, and estimation of direct and indirect effects have received much attention in recent
causal inference literature (Robins and Greenland, 1992; Robins, 1999, 2003; Pearl, 2001; Avin
et al., 2005; Taylor et al., 2005; Petersen et al., 2006; Ten Have et al., 2007; Goetgeluk et al., 2008;
van der Laan and Petersen, 2008; VanderWeele, 2009, 2011; VanderWeele and Vansteelandt, 2009,
2010; Imai et al., 2010a,b; Tchetgen Tchetgen, 2011; Tchetgen Tchetgen and Shpitser, 2014, 2012;
Tchetgen Tchetgen, 2013).
The particular effect we are interested in can be classified as a path-specific effect (Pearl, 2001)
– a class of estimands which can represent effects along any given causal pathway or collection
of causal pathways. We consider the effect along the path from the provision of ART to virologic
failure (or CD4 count) that goes through adherence, but not through toxicity. This effect is a
measure of the change in risk of virologic failure (or mean CD4 count) were one to intervene on
the mechanism by which the choice of treatment regimen directly, i.e., not through toxicity, affects
adherence. For instance, if the difference in the effectiveness of ART through adherence were due
to some regimens of ART having certain meal restrictions, posing a greater risk of patients missing
dosages due to issues with food insecurity (Eldred et al., 1998; Gifford et al., 1998; Roberts, 2000),
this effect would reflect the change in mean outcome if we were to modify the pills such that they
can be taken without any meal restrictions. We emphasize our focus on the pathway through
adherence, which does not involve toxicity, to learn about other possible mediating mechanisms
that may be as important as toxicity, but are currently underappreciated. The presence of an effect
through this pathway calls for closer investigation of these possible mechanisms, such as number of
pills taken per dosage or the requirement that they be taken with meals. The absence indicates that
differential effects through other pathways are driving the observed differences in effects among
the treatment assignments. In particular, the efficacies of the drugs themselves may, in fact, differ,
i.e., they may have a differential direct effect on the outcome with respect to adherence, or they
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may have a differential effect on adherence due to their differing levels of toxicity.
Pearl (2001) defines path-specific effects, and Avin et al. (2005) provide general necessary
and sufficient conditions for their identification for a single exposure and outcome, while Shpitser
(2013) generalizes these definitions and conditions to settings with multiple exposures, multiple
outcomes, and possible hidden variables. Our path-specific effect described above satisfies these
identifying conditions, however an estimation strategy for its identifying functional does not yet
exist. In this paper, we develop a suite of estimators (including a multiply-robust, semiparametric-
efficient estimator) for the effect. The HIV case study detailed in this paper also functions as
a guide for the application of this new method to analogous mediation settings where there is
confounding that is affected by the exposure.
1.2 Definitions
To formalize our discussion, we begin by defining variables and counterfactuals. We will be con-
sidering pairwise comparisons of first-line ARTs prescribed to most HIV patients in Nigeria. Let
E be an indicator of exposure to one of two such regimens of ART (coding given in Table 1.1).
For notational simplicity, let e0 denote the “reference level" treatment and e denote the “compar-
ison level" treatment. Let C1 be a bivariate vector of an indicator of any lab toxicities (alanine
transaminase  120 UI/L, Creatinine  260 mmol/L, Hemoglobin 8 g/dL) observed six months
after treatment initiation and an indicator that the patient’s average percent adherence during the
same six months, i.e., the total number of days that the patient had their drug supply divided by
the number of days in the six month period, was no less than 95%. LetM be an indicator that the
patient’s average percent adherence during the subsequent six months was no less than 95%. Let
Y be an indicator of whether the patient experienced virologic failure at the end of the year (based
on viral load measurements at twelve and eighteen months for confirmation), or alternatively CD4
count at twelve months. Let C0 be a vector of baseline confounders of the causal relationships
between E,M , and Y not affected by exposure, viz. sex, age, marital status, WHO stage, hepatitis
C virus, hepatitis B virus, CD4 count, and viral load. Throughout, we will assume that we observe
i.i.d. sampling ofO = (C0, E,C1,M, Y ).
We now consider counterfactuals under possible interventions on the variables (Rubin, 1974,
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C0 E C1 M Y
Figure 1.1: A causal graph with unobserved confounders that allows for identification of the
PEMY -specific effect
1978). Let Y (e⇤) denote a patient’s virologic suppression status or CD4 count if assigned, pos-
sibly contrary to fact, to the regimen of ART e⇤. In the context of mediation, there will also
be counterfactuals for intermediate variables. We define C1(e⇤), M(c1, e⇤) and Y (m, e⇤) simi-
larly, and adopt the standard set of consistency assumptions (Robins, 1986) that if E = e⇤, then
C1(e⇤) = C1 w.p.1, if E = e⇤ and C1 = c1, thenM(c1, e⇤) = M w.p.1, if E = e⇤ andM = m,
then Y (m, e⇤) = Y w.p.1, and if E = e⇤, then Y (e⇤) = Y w.p.1. Additionally, we adopt the
standard set of positivity assumptions (Robins, 1986) that fM |C1,E,C0(m|C1, E,C0) > 0 w.p.1 for
each m 2 supp(M), fC1|E,C0(c1|E,C0) > 0 w.p.1 for each c1 2 supp(C1), fE|C0(e⇤|C0) > 0
w.p.1 for each e⇤ 2 {e0, e}.
To define the path-specific effect along the path E ! M ! Y , which we denote PEMY , we
begin by discussing the graph in Figure 1.1. This is a complete graph of all observed variables
in the sense that it includes all possible directed arrows that follow the natural temporal ordering.
That is, any variable may directly affect any other variable succeeding it under this graph. The
graph departs from the standard mediation graph (Baron and Kenny, 1986) in two important ways.
The first is with the presence of C1, which allows confounders of the effect of the mediator
on the outcome to be affected by the exposure. In our HIV context, C1 contains toxicity, which is
clearly affected by the treatment assignment and may confound the effect of adherence on virologic
failure. One way in which it might do this is on a biological level, toxicity might have an interactive
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effect with the drugs on the outcome, allowed for by the presence of the directed arrow from C1
to Y in conjunction with the directed arrow from E to Y . Thus, toxicity is a common cause of the
outcome and adherence and, therefore, a confounder. Such a confounder is known as a recanting
witness, due to its role in telling two conflicting “stories" about how E affects Y by being involved
in two different pathway from E to Y – one involving M and the other not. Avin et al. (2005)
showed the natural (or pure) direct and indirect effects (NDE and NIE, both highly popular in the
mediation literature) (Robins and Greenland, 1992; Pearl, 2001) to be unidentified in the presence
of a recanting witness.
The second way the graph in Figure 1.1 departs from the standard mediation graph is by the
presence of the gray bidirected edges betweenC0,C1, and Y , each of which represents unobserved
common causes between the two nodes to which it points. In the HIV application, these bidirected
edges allow for the possibility of underlying biological factors which may be unobserved common
causes of toxicity, the outcome, and biological baseline measurements such as viral load. The
presence of these bidirected edges induces confounding of the effect of adherence on the outcome
via toxicity, even if the arrow directed from C1 to Y is absent. Since early adherence (during the
first six months) may confound the effect of adherence at a later stage (during the subsequent six
months) on the outcome, early adherence must be included inC1. Thus, PEMY involves only later
adherence, and neither toxicity nor early-stage adherence.
As described above, we wish to quantify the mediating role of adherence along PEMY in Fig-
ure 1.1 which does not involve toxicity. Effects along such arbitrary (bundles of) causal pathways
are known as path-specific effects (Pearl, 2000; Avin et al., 2005; Shpitser, 2013) and it is possible
to define them inductively, which results in a quantity that is a function of a nested counterfactual
(Shpitser, 2013). A general definition for the static-treatment and single-outcome case is given by
Pearl (2000) and Avin et al. (2005). Defining
 0 ⌘ E[Y (M(e,C1(e0)),C1(e0), e0)]
 0 ⌘ E[Y (M(e0,C1(e0)),C1(e0), e0)],
the PEMY -specific effect, with respect to the comparison treatment value e and the baseline treat-
ment value e0 on the mean difference scale, is given by  0    0.  0 gives the mean outcome had
everyone been assigned to the reference treatment regimen.  0 gives the mean outcome had every-
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one been assigned to the reference treatment regimen, and adhered as they would have based on
the toxicity they experienced from this regimen, but otherwise as if they had been assigned to the
comparison treatment. This is the PEMY -specific effect since it captures the impact of changing
M(e0) to M(e,C1(e0)), which in turn would lead to an effect on Y only if M affects Y directly
when all patients are assigned to e0.
1.3 Identification
Before introducing our identification result, we must first introduce a model that relaxes the as-
sumption of independent errors of the Markovian model (Pearl, 2000) in a natural way. We will
associate this model with the graph in Figure 1.1. This model consists of a set of equations, one
for each variable in the graph. With each random variable on the graph is associated a distinct,
arbitrary function, denoted g, and a distinct random disturbance, denoted ", each with a subscript
corresponding to its respective random variable. A component in a graph connected by bidirected
edges (i.e., connected when ignoring directed edges) is known as a district (Richardson, 2009)
or c-component (Tian and Pearl, 2002). The sets of random disturbances corresponding to each
district are assumed to be mutually independent of one another. That is, {"C0 , "C1 , "Y }, "E , and
"M are mutually independent; "C0 , "C1 , and "Y , however, are not. Each variable is generated
by its corresponding function, which depends only on all variables that directly affect it (i.e., its
parents on the graph), and its corresponding random disturbance, as follows: C0 = gC0("C0),
E = gE(C0, "E),C1 = gC1(C0, E, "C1),M = gM(C0, E,C1, "M), Y = gY (C0, E,C1,M, "Y ).
Just as the Markovian model, the model we introduce is especially useful for making coun-
terfactual independence assumptions explicit. Take for instance the statement {Y (m, e0),C1(e0)}
?? M(c1, e)|C0. To see whether this statement holds in the context of the graph in Figure 1.1,
observe what occurs when we intervene on the mechanism in one case to force the exposure to be
the comparison level, e, and set C1 to an arbitrary value c1: C0 = gC0("C0), E = e, C1 = c1,
M(c1, e) = gM(C0, e, c1, "M), Y (c1, e) = gY (C0, e, c1,M(c1, e), "Y ); and in another case to
force the exposure to be the reference level, e0, and setM to an arbitrary valuem: C0 = gC0("C0),
E = e0, C1(e0) = gC1(C0, e0, "C1),M = m, Y (m, e0) = gY (C0, e0,C1(e0),m, "Y ). Note that the
only sources of stochasticity in M(c1, e) are C0 and "M , and the only sources of stochasticity in
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{Y (m, e0),C1(e0)} are C0, "C1 , and "Y . Hence the only source of dependence between the two is
C0 since "M ?? {"C1 , "Y }, and they are independent conditional on C0. We are now prepared to
present our identification result, whose proof is provided in the supplementary materials.
Theorem 1.1. Suppose the data-generating mechanism from which the observed dataO are sam-
pled follows the relaxation of the Markovian model that we introduce above, represented by the
graph in Figure 1.1. Then  0 is identified under this model by the following functional of FO:
 0 =
ZZZ
m,c1,c0
E(Y |m, c1, e0, c0)dF (m|c1, e, c0)dF (c1|e0, c0)dF (c0). (1.1)
Remark. The following conditions are sufficient for the same identification result, and are strictly
weaker than those implied by our model: for all m, c1, e, and e0, {Y (m, e0),C1(e0)} ?? E|C0,
Y (m) ??M |C1, E,C0,M(c1, e) ?? {C1, E}|C0, {Y (m, e0),C1(e0)} ??M(c1, e)|C0.
Theorem 1.1, in conjunction with the standard g-formula result  0 =
R
c0
E(Y |e0, c0)dF (c0)
(Robins, 1986), which holds under the assumption encoded on the diagram that Y (e0) ?? E|C0,
identifies the PEMY -specific effect,  0    0.
1.4 Path-specific inference
Thus far, we have only considered a nonparametric modelMnonpar for the observed data, making
our identifying functional of the PEMY -specific effect valid under any possible correct model for
the data. Unfortunately, we will seldom have the luxury to continue using Mnonpar through the
estimation stage; because inference in Mnonpar is rarely practical in situations with numerous or
continuous confounders (C0,C1) (Robins et al., 1997), we will often be forced to posit paramet-
ric models. Which models we are to fit depend on how we choose to estimate (1.1). We now
consider four estimators and the corresponding models needed to compute them. Note that, while
these estimators are in fact asymptotically equivalent under a nonparametric model, they will have
different asymptotic properties under parametric and semiparametric models (Tchetgen Tchetgen
and Shpitser, 2012).
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1.4.1 Maximum Likelihood Estimation
We first discuss the maximum likelihood estimator (MLE) for  0. By considering the identifying
functional (1.1) as four nested expectations, it is clear that we can fit three appropriate regression
models with parameters  1,  2, and  3 using maximum likelihood, and plug the predicted means
under these models into the functional; the outermost mean can then be estimated empirically. If
the conditional mean of Y is taken to be linear in M and C1, and the conditional mean of M is
taken as linear in C1, then mean models can be fit for Y ,M , and C1. Thus, the MLE is
 ˆmle ⌘ Pn
n
Eˆ(Eˆ(Eˆ(Y |M,C1, e0,C0;  ˆ1)|C1, e,C0;  ˆ2)|e0,C0;  ˆ3)
o
,
where Pn denotes the empirical mean.
Define   ⌘ ( 1, 2, 3), g( ) ⌘ Eˆ(Eˆ(Eˆ(Y |M,C1, e0,C0; 1)|C1, e,C0; 2)|e0,C0; 3),
D  ⌘ E[r g( )], and U( ) and I( ) to be the vector of score equations and block-diagonal
matrix of expected informations, respectively, for  . Let  0 be the true value of  . Then  ˆmle
is asymptotically normal with asymptotic variance equal to E[(g( 0) +DT 0I( 0)U( 0)   0)2],
which can be estimated empirically, substituting  ˆ and  ˆmle for  0 and  0. The MLE is asymptoti-
cally efficient when the three regression models are correctly specified, hence this is the minimum
variance achievable by regular, asymptotically linear estimators under the choice of model Mpar
ofO.  ˆmle will be consistent only under correct specification of the three models.
1.4.2 Multiply-Robust Estimation
The multiply-robust (MR) estimator,  ˆmr, comes from an estimating equation involving the effi-
cient influence function of  0 in the model Mnonpar placing no restriction on the observed data
likelihood apart from the positivity assumptions given above. A derivation of this influence func-
tion is given in the supplementary materials. In order to express the estimator more succinctly, we
introduce additional notation: B(m, c1, e0, c0) ⌘ E(Y |m, c1, e0, c0), B0(c1, e0, e, c0) ⌘ E{E(Y |
M, c1, e0, c0)|c1, e, c0}, B00(e0, e, c0) ⌘ E[E{E(Y |M,C1, e0, c0)|C1, e, c0}|e0, c0], M ratio ⌘ f(
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M |C1, e,C0)/f(M |C1, e0,C0), and Cratio1 ⌘ f(C1|e,C0)/f(C1|e0,C0). The estimator is then
 ˆmr =Pn
⇢
1e0(E)
fˆ(e0|C0)
Mˆ ratio
n
Y   Bˆ(M,C1, e0,C0)
o
+
1e(E)
fˆ(e|C0)
(Cˆratio1 )
 1
n
Bˆ(M,C1, e
0,C0)  Bˆ0(C1, e0, e,C0)
o
+
1e0(E)
fˆ(e0|C0)
n
Bˆ0(C1, e0, e,C0)  Bˆ00(e0, e,C0)
o
+ Bˆ00(e0, e,C0)
 
,
where 1e⇤(·) is the indicator function, Bˆ0(C1, e0, e,C0) = Eˆ{Bˆ(M,C1, e0,C0)|C1, e,C0}, and
Bˆ00(e0, e,C0) = Eˆ[Eˆ{Bˆ(M,C1, e0,C0)|C1, e,C0}|e0,C0].
Note that the estimator is only a function of estimates of fM |C1,E,C0 and fC1|E,C0 through
the ratios M ratio and Cratio1 and mean functions B0(C1, e0, e,C0) and B00(e0, e,C0). When the
mean of Y is linear inM , then B0(C1, e0, e,C0) only depends on the distribution ofM through its
conditional mean, E(M |C1, e,C0). Similarly, if in addition the means of Y andM are both linear
in C1, then B00(e0, e,C0) only depends on the distribution of C1 through its conditional mean,
E(C1|e0,C0). We denote ✓M ⌘ {B0(C1, e0, e,C0),M ratio} and ✓C1 ⌘ {B00(e0, e,C0), Cratio1 }.
B, ✓M , ✓C1 , and fE|C0 are estimated using low dimensional parametric working models,
BW , ✓WM = {EW [BW (M,C1, e0,C0)|C1, e,C0],M ratio;W}, ✓WC1 = {EW [B0W (C1, e, c0)|e0,C0],
Cratio:W1 }, and fWE|C0 , via standard maximum likelihood. Note that we are able to avoid estimating
the densities for C1 andM by instead estimating their mean functions and density ratios directly.
Mean functions can be estimated with standard regression techniques, and density ratios can be
estimated using propensity score models since by Bayes’ theorem,
f(C1|e,C0)
f(C1|e0,C0) =
f(e|C1,C0)
f(e0|C1,C0) ⇥
f(e0|C0)
f(e|C0)
and
f(M |e,C1,C0)
f(M |e0,C1,C0) =
f(e|M,C1,C0)
f(e0|M,C1,C0) ⇥
f(e0|C1,C0)
f(e|C1,C0) .
An attractive property of the multiply-robust estimator is its robustness to multiple types of
potential model misspecification. Let Bˆ, ✓ˆM, ✓ˆC1 , and fˆE|C0 denote estimators of BW , ✓WM ,
✓WC1 , and f
W
E|C0 consistent under correct specification. The mean functions in ✓M and ✓C1 require
correct specification of the functions ofM andC1 based on the working models for Y and {M,Y },
respectively, so that ✓WM and ✓WC1 can be correctly specified regardless of whether B
W is, and
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✓WC1 can be correctly specified regardless of whether ✓
W
M is. The multiply-robust estimator is
consistent and asymptotically normal (under standard regularity conditions) provided that one of
the following holds: (a) {✓M , fE|C0} 2 {✓WM , fWE|C0}, (b) {B,✓C1 , fE|C0} 2 {BW ,✓WC1 , fWE|C0},
(c) {B,✓C1 ,✓M} 2 {BW ,✓WC1 ,✓WM }. That is,  ˆmr offers three distinct opportunities to obtain
valid inference about the path-specific effect. By contrast,  ˆmle will be consistent only if a slightly
weaker form of (c) holds, whereM ratio;W and Cratio;W1 need not be correctly specified.
For inference on  ˆmr, we recommend the nonparametric bootstrap (Efron, 1979) or similar
alternative resampling methods such as the randomly weighted bootstrap (Rao and Zhao, 1992;
Van Der Vaart and Wellner, 1996) for nonparametric variance estimation. Due to its reliance on
inverse-propensity-score weights, this estimator may suffer from instability in settings where the
set of positivity assumptions is nearly violated (Kang and Schafer, 2007). A useful stabilization
technique is to simply replace any propensity score fˆE|X with fˆ †E|X, where X is some vector of
covariates and logitfˆE|X(e|X) = logitfˆE|X(e|X)   log(1   Pn(1e(E))) + log(Pn[1e(E)fˆE|X(e0|
X)/fˆE|X(e|X)]), which ensures the weights are bounded as discussed in Tchetgen Tchetgen and
Shpitser (2012). An additional stabilization technique is given in the supplementary materials.
1.4.3 Other Estimators
We consider two additional estimators, both based on alternative representations of (1.1) as shown
in the supplementary materials:
 ˆa ⌘ Pn
(
1e0(E)
fˆ(e0|C0)
Mˆ ratioY
)
 ˆb ⌘ Pn
(
1e(E)
fˆ(e|C0)
(Cˆratio1 )
 1Eˆ(Y |M,C1, e0,C0)
)
,
which again involve plugging in estimated regression models and density curves fˆ(e|M,C1,C0),
fˆ(e|C1,C0), and fˆ(e|C0). Note that  ˆa and  ˆb depend only on a subset of the models in the
multiple-robustness conditions (a) and (b), respectively. It follows that  ˆa will generally be con-
sistent only if a slightly weaker form of (a) holds, where B0W need not be correctly specified.
Similarly,  ˆb will be consistent only if a slightly weaker form of (b) holds, where B00W need not
be correctly specified. In settings with practical violations of positivity, stability of both estimators
can be improved using the stabilization technique given in Section 1.4.2.
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1.5 Simulation study
We report results for a simulation study in which we generated 1000 data sets of size 1000 from
the following models:
C0 ⇠ U(0, 2)
E|C0 ⇠ Bernoulli
 
1  (1 + exp(0.9 + 0.3C0)) 1
 
C1 =
0@ 0.80.6
 0.3
1A+
0@ 10.1
0.2
1AC0 +
0@ 0.5 0.4
0.5
1AE +
0@ 0.10.8
 0.2
1AC0E +N (0, I)
M =  0.5  0.2C0 + 0.3E + [ 0.2, 0.1, 0.5]C1 + [0.4, 0, 0]EC1 +N(0, 1)
Y = 0.2 + 0.2C0 + 0.6E + [1, 0.7, 0.3]C1   0.9M   0.8EM +N(0, 1).
In order to investigate the impact of model misspecification, we computed each of the four esti-
mators given above,  ˆmr,  ˆmle  ˆa, and  ˆb, under the four parametric models, Ma, Mb, Mc, and
Mint. ModelsMa,Mb, andMc were specified such that statements (a)-(c) in Section 1.4.2 cor-
responding to their respective subscripts held, but the models for the remaining estimands were
incorrectly specified. For instance, underMa, models ✓WM and fWE|C0 are correctly specified, while
BW and ✓WC1 are not. The intersection model uses correctly-specified working models. All models
were fit by maximum likelihood. The stabilization technique described in Section 1.4.2 was used
to adjust propensity scores. We used the following working models, subscripted C for correctly
specified and I for incorrectly specified:
fWE|C0:
Correct: logit PrC{E = 1|C0} = [1, C0]↵C
Incorrect:   1(PrI{E = 1|C0}) = [1, C0]↵I
BW :
Correct: EC [Y |M,C1, E, C0] = [1, C0, E,C1,M,EM ]⌘C
Incorrect: EI [Y |M,C1, E, C0] = [1, C0, E,C1,M ]⌘I
✓WC1 :
Correct: Cratio;W1 = PrC(E = e|C1, C0)/PrC(E = e0|C1, C0) ⇥ PrC(E = e0|C0)PrC(E =
e|C0), which depends on the correctly-specified fWE|C0 model and the correctly-specified model
logit PrC{E = 1|C1, C0} = [1, C0, C20 ,C1, C0C1] C ;
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B00C(e
0, e, C0) = EC [EC{EC(Y |M,C1, e0, C0)|C1, e, C0}|e0, C0], which depends on the correctly-
specified BW model and the correctly-specified models EC [C1j|E,C0] = [1, C0, E, C0E] j;C 8j
2 {1, 2, 3} and EC [M |C1, E, C0] = [1, C0, E,C1, EC11]⇣C .
Incorrect: Cratio;W,I1 = PrI(E = e|C1, C0)/PrI(E = e0|C1, C0)⇥ PrC(E = e0|C0)/PrC(E =
e|C0), which depends on the correctly-specified fWE|C0 model and the incorrectly-specified model
logit PrI{E = 1|C1, C0} = [1, C0,C1] I ;
B00I (e
0, e, C0) = EI [EC{EI(Y |M,C1, e0, C0)|C1, e, C0}|e0, C0], which depends on the incorrectly-
specified BW model, the correctly-specified working mean model for M used for B00C(e0, e, C0)
above, and the incorrectly-specified model EI [C1j|E,C0] = [1, C0, E] j,I , since ✓WC1 is only mis-
specified in setting (a), under which BW is also misspecified and ✓WM is correctly specified.
✓WM :
Correct: M ratio;W,C = PrC(E = e|M,C1, C0)/PrC(E = e0|M,C1, C0) ⇥ PrC(E = e0|C1,
C0)/PrC(E = e|C1, C0), which depends on the correctly-specified model logit PrC{E = 1|M,
C1, C0} = [1, C0, C20 ,C1, C0C1, C11C1,M,C11M ] C and the correctly-specified logistic model
used for Cratio;W1 above;
B0C(C1, e
0, e, C0) = EC{EC(Y |M,C1, e0, C0)|C1, e, C0} depends on the correctly-specified BW
model and the correctly-specified mean model forM used for B00C(e0, e, C0) above.
Incorrect: M ratio;W,I = PrI(E = e|M,C1, C0)/PrI(E = e0|M,C1, C0) ⇥ PrC(E = e0|C1,
C0)/PrC(E = e|C1, C0), which depends on the correctly-specified logistic model for PrC{E = 1|
C1, C0} and the incorrectly-specified model logit PrI{E = 1|M,C1, C0} = [1, C0,C1,M ] I ;
B0I(C1, e
0, e, C0) = EI{EC(Y |M,C1, e0, C0)|C1, e, C0}, which depends on the incorrectly-spec-
ified model EI [M |C1, E, C0] = [1, C0, E,C1]⇣I and the correctly-specified model BW,C , since
✓WM is only misspecified in setting (c), under which BW is correctly specified.
The results are summarized in the plot displayed in Figure 1.2 that shows the four point es-
timates under each model and their corresponding 95% confidence intervals. The point estimates
are the Monte Carlo means of the 1000 samples and the confidence intervals are the values within
t999,0.975 times the corresponding Monte Carlo standard errors of the point estimates. The confi-
dence intervals correspond to t tests of H0 :  ˆ =  0 ⌘ 2.678, hence the confidence intervals not
containing  0, represented by the horizontal dashed line, correspond to rejection of H0.
All estimators are consistent under Mint. Besides  ˆmr,  ˆa is the only consistent estimator
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Figure 1.2: Simulation results for n=1000. Monte Carlo point estimates and confidence intervals
of each of the four PEMY -specific estimators are given under Mint, Ma, Mb, and Mc. The
horizontal dashed line is through the true parameter value,  0.
underMa,  ˆb is the only consistent estimator underMb, and  ˆmle is the only consistent estimator
underMc.  ˆmr is consistent under all models. Therefore, in moderate to large samples, we expect
to reject H0 at the nominal ↵ = 0.05 level for none of the estimators underMint, only for  ˆb and
 ˆmle underMa, only for  ˆa and  ˆmle underMb, and only for  ˆa and  ˆb underMc.
The results illustrate quite well the multiple-robustness property of  ˆmr. As predicted, while
the other estimators failed to estimate  0 without statistically-significant bias, the tests for  ˆmr
failed to reject under every model. For the other estimators, the tests never rejected under Mint
and their corresponding models where the misspecified components did not factor into estimation,
as expected. That is, the test for  ˆa did not reject under Ma, the test for  ˆb did not reject under
Mb, and the test for  ˆmle did not reject underMc. The tests did reject, however, under the other
models, with the exception of  ˆc underMb. Thus, all estimators other than  ˆmr were significantly
biased under at least one model.
We do see a tradeoff between efficiency and robustness; in all settings,  ˆmle and  ˆb perform
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best in terms of efficiency, with a slight advantage going to  ˆmle. As such, a reasonable strategy
may be to use these estimators in concert initially to diagnose model specification, and then select
the most efficient estimator that appears to agree with the multiply-robust estimator, possibly  ˆmr
itself.
Other sample sizes were also explored. At n = 500, asymptotic results began to come into
focus, though a few of the tests expected to reject looked to be slightly underpowered due to
the sample not being large enough. Still, the multiply-robust estimator outperformed the other
estimators at this sample size in terms of robustness. At n = 5000, confidence intervals were
tighter, as expected, but t test results were the same as those at n = 1000. The simulation study with
n = 1000 is comparable to our data analysis in terms of sample size; every treatment comparison
consisted of at least 1000 patients.
1.6 Harvard PEPFAR Nigeria analysis
We now present results of the Harvard PEPFAR data analysis. The data set consisted of 9968 com-
plete observations, i.e., observations with no missing variables, which was 41.9% of the entire data
set. We first consider the path-specific effect of treatment regimen assignment on virologic failure
through adherence, expressed on the log-risk ratio scale. We used each of the four estimators for  0
from Section 1.4, and in each case,  0 was estimated using only a subset of the models used to esti-
mate  0. In particular, the doubly-robust estimator (Bang and Robins, 2005) was used to estimate  0
when contrasted with  ˆb and the multiply-robust estimator,  ˆmr; the inverse-probability-weighted
estimator (IPW) (Horvitz and Thompson, 1952) was used to estimate  0 when contrasted with  ˆa;
and the MLE was used to estimate  0 when contrasted with the MLE for the  0,  ˆmle. Accord-
ingly, let PˆEMY ;mle denote the effect estimate using  ˆmle, PˆEMY ;a denote the effect estimate using
 ˆa, PˆEMY ;b denote the effect estimate using  ˆb, and PˆEMY ;mr denote the effect estimate using  ˆmr.
We computed all four estimates and corresponding bootstrap confidence intervals for each pairwise
comparison of treatments. A randomly weighted bootstrap (Rao and Zhao, 1992; Van Der Vaart
and Wellner, 1996) with weights sampled from Exp(1) was used to account for instability of re-
samples due to a small number of cases in some strata of E. Results are summarized in Figure C.1
of the supplementary materials.
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PˆEMY ;a agreed with PˆEMY ;mr across all comparisons, suggesting that it did not suffer much
from model misspecification, or at least any worse than did PˆEMY ;mr. It also proved to be the
more efficient estimator in this setting, with confidence intervals that were narrower than those of
PˆEMY ;mr, and comparable to those of PˆEMY ;mle, which did not appear to be as robust. Thus, we
chose to perform inference using PˆEMY ;a for this portion of the analysis.
Recall that the treatment regimens were coded in descending order of magnitude of their total
effects on risk of virologic failure, i.e., they were coded in ascending order of counterfactual risk
of virologic failure had everyone been assigned to that treatment, since a lower counterfactual
risk of failure corresponds to a higher magnitude of total effect. Because in practice we are more
interested in learning how less-effective treatments can be improved, we only consider the higher-
coded treatment in a pair as the baseline, e0. Using this ordering, the path-specific effect gives the
improvement over the total effect of the less-effective treatment when intervening to make patients
adhere as if they were on the more-effective treatment, but had the toxicity and direct effectiveness
of the less-effective treatment.
We are primarily interested in the proportion of the total effect attributable to the mediated
effect, i.e., the percent mediated by PEMY . If this proportion is close to or exceeds one, we can
conclude that the drugs themselves likely have the same effectiveness on virologic failure, and
that it is their differential effect on adherence not due to toxicity that is driving the difference in
total effects. If, on the other hand, this proportion is small or negative, we can only say that the
difference in total effects is not driven by a difference in effects through PEMY . It may be the case
that the efficacies of the drugs themselves do, in fact, differ, or that the difference in total effects is
driven by the differential effect on adherence due to toxicity, but we cannot confirm either. Table
1.2 shows PˆEMY ;a divided by the total effect estimates, which are also on the log-risk ratio scale
and are estimated by IPW. Superscripts indicate the comparisons with significant and marginally-
significant path-specific effects. Due to the treatment coding, the denominators of the Table 1.2
values are always negative. Thus, a negative path-specific effect will be in the same direction as
the total effect, and hence will explain a positive proportion of it.
Note that all significant and marginally-significant proportions of total effects due to the effects
through PEMY were negative apart from the one comparing treatment 1 (TDF+3TC/FTC+EFV)
to baseline treatment 2 (d4T+3TC+NVP). This occurs when the PEMY -specific effect estimate
18
Table 1.2: Proportion of total effect on virologic failure due to PEMY -specific effect
Baseline treatment
Comparison trt 2 3 4 5
1 0.41† 0.21 -0.059 -0.068⇤
2 - 0.13 -0.49⇤ -0.20⇤
3 - - -0.57† -0.13⇤
4 - - - -0.027†
NOTE: ⇤Significant path-specific effect (↵ = 0.05). †Marginally-significant path-specific effect
(↵ = 0.1).
is in the opposite direction of the total effect estimate, suggesting that directionally-opposite ef-
fects through other pathways overwhelm our estimated effect, and that the total effect would
have been even greater if not for the PEMY -specific effect. For example, had the PEMY -
specific effect been null in the case comparing treatment 3 (AZT+3TC+EFV) with treatment 5
(TDF+3TC/FTC+NVP), we estimate that the total effect would have been 13% larger. The effect
of treatment 3 is stronger than 5 not because of its effect through PEMY , but in spite of it. All
differences between treatment 5 and another treatment, and all differences between treatment 4
(AZT+3TC+NVP) and another treatment besides 1 were observed to exhibit this phenomenon as
well.
Now consider the exception noted above: the comparison of treatment 1
(TDF+3TC/FTC+EFV) to baseline treatment 2 (d4T+3TC+NVP). We saw a marginally-
negative effect, which would have the following interpretation: the effect of treatment 2 on the risk
of virologic failure would be improved by patients adhering as if they were assigned to treatment
1, but still had the same toxicity that they did on treatment 2. Unfortunately, treatment 2 is known
to have toxicities that were not measured in this data set that are likely to also be affected by
underlying biological causes of virologic failure. This interpretation cannot even be considered
to be valid for the effect through these unmeasured toxicities, since they induce unmeasured
confounding that once again renders this effect unidentifiable. If there were no unmeasured
toxicities, we would interpret this effect as accounting for an estimated 41% of the differences in
total effects between treatments 1 and 2.
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In conclusion, of the significant PEMY -specific effects we observed, all apart from those in-
volving unmeasured toxicities were countervailing to the total effect. This means that for these
treatment pairs, the differences in their total effects on virologic failure would have been even
greater if not for the effect along PEMY . Thus, the effect through PEMY does not explain the dif-
ferential effects on virologic failure, and in some cases actually works against them. As mentioned
above, the differential effects may instead be due to the drugs themselves differing in efficacy, or
they may be driven by the differential effects on adherence due to toxicity, but such hypotheses
require further investigation beyond the scope of our analysis.
We now consider the path-specific effect of treatment regimen assignment on log CD4 count,
expressed on the mean difference scale. We again analyzed the four estimators given in Section 1.4.
This time PˆEMY ;a and PˆEMY ;b were drastically less efficient than PˆEMY ;mle and PˆEMY ;mr. One
possible explanation for this is that the density of log CD4 count was less concentrated around zero,
making PˆEMY ;a and PˆEMY ;b more sensitive to small weights. PˆEMY ;mle disagreed with PˆEMY ;mr
on several occassions, so PˆEMY ;mr was the best choice in terms of achieving both robustness and
efficiency. It is worth noting that the linear outcome model for CD4 count did not seem to suffer
too much frommisspecification, while the logistic outcome model for virologic failure did. Results
are summarized in Figure C.2 of the supplementary materials.
Table 1.3 shows PˆEMY ;mr divided by the total effect estimates, which are also on the log-
risk ratio scale and are estimated using doubly-robust estimators. As before, we are interested in
Table 1.3: Proportion of total effect on CD4 count due to PEMY -specific effect
Baseline treatment
Comparison trt 3 1 5 2
4 0.48⇤ 0.095 -0.045† 0.036
3 - -0.47 -0.13 0.030
1 - - -0.080 0.062
5 - - - 0.099
NOTE: ⇤Significant path-specific effect (↵ = 0.05). †Marginally-significant path-specific effect
(↵ = 0.1).
learning how the less-effective treatment can be improved, but now less-effective is in terms of
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CD4 count. Since the order of the effectiveness of the treatments for CD4 count is not the same as
the order for virologic failure, the treatments which should be considered the comparison versus
baseline level in a pair no longer correspond to the treatment coding. The order of the treatments
in the margins of Table 1.3 is rearranged to reflect this different ordering of effectiveness. The
denominator for each of the values in the table is positive, since a higher counterfactual CD4 count
corresponds to a higher magnitude of total effect. Therefore, positive proportions correspond to
positive path-specific effects, and negative proportions correspond to countervailing path-specific
effects.
The path-specific effect was found to be significant for only one of the pairwise compar-
isons: treatment 4 (AZT+3TC+NVP) vs. treatment 3 (AZT+3TC+EFV). This effect is estimated
to be in the positive direction, therefore we conclude that the effect of treatment 3 on CD4 count
would be improved by patients adhering as if they were assigned to treatment 4 but without nec-
essarily altering toxicity experienced under treatment 3 that they did on treatment 3. The effect
through this pathway accounted for almost half of the total effect at an estimated 48%. Thus,
if one were interested in improving the effect of AZT+3TC+EFV on CD4 count, it would be
worthwhile to examine what mechanisms other than toxicity may be implicated in differential
adherence rates between these two regimens. The PEMY -specific effect comparing treatments 4
and 5 (TDF+3TC/FTC+NVP) was found to be marginally-significantly less than zero. Thus, the
difference in total effects of these two treatments is not attributable to their differential effect on
adherence not due to toxicity, as the effect through this pathway was in fact in the opposite direc-
tion. Rather, this difference was due to differential effects through other pathways as previously
described.
1.7 Discussion
In the PEPFAR case study, we observed an interesting trend of countervailing effects along PEMY
to the total effects on virologic failure for most treatment comparisons, meaning that the differences
in the total effects of treatment assignment would have been even greater if not for the effects along
PEMY . While this does not help explain why the treatment assignment effects are different (or at
least different in the direction that we observe), it does suggest a method for improving the regi-
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mens that we observed to have greater effects on virologic failure. For a treatment comparison with
a significant PEMY -specific effect, if we could identify what is different about the more effective
drug regimen that is causing people to not adhere to it as well, then we could potentially elimi-
nate this mechanism in order to reduce the countervailing PEMY -specific effect and consequently
improve its total effect on virologic failure.
A countervailing PEMY -specific effect on CD4 count was also observed between
AZT+3TC+NVP and TDF+3TC/FTC+NVP, which has the same interpretation as the counter-
vailing effects on virologic failure. On the other hand, almost half of the difference in the effects
of AZT+3TC+EFV and AZT+3TC+NVP on CD4 count was found to be attributable to the effect
through adherence, but not toxicity. This suggests that the effect of AZT+3TC+EFV on CD4 count
could be improved up to that of AZT+3TC+NVP if one could identify and eliminate the mecha-
nisms driving the difference in these treatments’ effects on adherence. In the other treatment
comparisons, none of the differences in total effects on CD4 count were found to be attributable
to an effect through PEMY . Overall, we have achieved an enhanced understanding of the role of
adherence in the effects of the five ART regimens considered on both virologic failure and CD4
count.
The most significant methodologic contribution of this paper is the extension of mediation
analysis methods to settings in which the NDE and NIE may not be identified, viz. settings with
unmeasured confounding and exposure-induced confounding of the mediator. We present condi-
tions under which the PEMY -specific effect is nonparametrically identified as well as four estima-
tors, including an efficient estimator that is multiply robust to model misspecification for settings
where nonparametric estimation is not feasible.
Often effects of adherence are evaluated regarding the treatment assignment as an instrumental
variable, relying on an assumption of no direct effect of assignment with respect to adherence.
Furthermore, instrumental variable methods rely on an assumption of monotonicity in the effect
of assignment on adherence. However, neither of these assumptions are reasonable in our setting
where we are forced to compare treatments head-to-head rather than to a control exposure level.
This paper suffers from a few limitations. One is that our identifiability assumptions, though
weaker than those of the Markovian model, are still untestable as stated. When possible, we can
embed our mediation problem in a larger model represented by a larger graph where treatments can
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be split into a component corresponding to the EMY pathway and a component corresponding
to all other pathways. This can provide a testable reformulation of identifying assumptions, as
was done in Robins and Richardson (2010) in simpler mediation contexts. Another limitation
is that this method is not yet equipped to handle missing data. As such, only a complete-case
analysis was conducted for the HIV data, allowing for the possibility of bias due to informative
missingness. Additionally, for both virologic failure and CD4 count outcomes, it is possible that
we are underestimating the effect of substantive interest if adherence over the first six months plays
a large mediating role since we are forced to control for early adherence and can only estimate the
effect through adherence over the second six months. Finally, not a limitation, but rather a caveat,
is that the PEMY -specific effect is not a substitute for the NIE. The NIE is not fully captured by
this effect and, in fact, even if the effects along both PEMY and E ! C1 ! M ! Y are in the
same direction, the NIE does not necessarily have to be. Strong assumptions are needed to draw
this conclusion. As such, while often practically meaningful, the PEMY -specific effect must be
interpreted with care and not blindly substituted for the NIE.
Future directions for this work would, of course, include adjusting the method to account for
missing data, which could improve the analysis conducted in this paper. Another important exten-
sion would be to the full longitudinal case, with repeated exposures, mediators, and confounders.
Shpitser (2013) gives the identifying functional for the analog to the PEMY -specific effect in this
setting, but no estimation strategy exists as of yet. Finally, it is not uncommon for a mediator to be
measured with error, which tends to induce bias as shown by VanderWeele et al. (2012). It would
be valuable to adapt the methods of Tchetgen Tchetgen and Lin (2012) for handling this problem
to our setting. Alternatively, parametric approaches have been suggested (Valeri et al., 2014) that
could also potentially be adapted.
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2.1 Introduction
Causal mediation analysis seeks to determine the role that an intermediate variable plays in “trans-
mitting” the effect from an exposure to an outcome. An “indirect effect” refers to the effect that
goes through the intermediate variable in mediation analysis; a “direct effect” is a measure of the
effect that does not. The study of causal mediation has in recent years enjoyed an explosion in
popularity (Robins and Greenland, 1992; Robins, 1999, 2003; Pearl, 2001; Avin et al., 2005; Tay-
lor et al., 2005; Petersen et al., 2006; Ten Have et al., 2007; Goetgeluk et al., 2008; van der Laan
and Petersen, 2008; VanderWeele, 2009, 2011; VanderWeele and Vansteelandt, 2009, 2010; Imai
et al., 2010a,b; Tchetgen Tchetgen, 2011; Tchetgen Tchetgen and Shpitser, 2014, 2012; Shpitser,
2013; Tchetgen Tchetgen, 2013), not only in terms of theoretical developments, but also in prac-
tice, most notably in the fields of epidemiology and social sciences. This strand of work is based
on ideas originating from Robins and Greenland (1992) and Pearl (2001) grounded in the language
of potential outcomes (Splawa-Neyman et al., 1990; Rubin, 1974, 1978) to give a nonparametric
definition of effects involved in mediation analysis, allowing for settings where certain interactions
and nonlinearities may be present.
Consider an intervention which sets the exposure of interest for all persons in the population
to one of two possible values, a reference value or an active value. The total effect of such an
intervention corresponds to the change of the counterfactual outcome mean if the exposure were
set to the active value compared with if it were set to the reference value. Robins and Greenland
(1992) formalized the concept of effect decomposition of the total effect into direct and indirect
effects by defining pure direct and indirect effects. Pearl (2001) relabeled these effects as natural
direct and indirect effects. The natural direct effect corresponds to the change in the counterfactual
outcome mean under an intervention which changes a person’s exposure status from the reference
value to the active value, while maintaining the person’s mediator to the value it would have had
under the exposure reference value. In contrast, the natural indirect effect corresponds to the
change in the average counterfactual outcome under an intervention that sets a person’s exposure
value to the active value, while changing the value of the mediator from the value it would have
had under the reference exposure value, to its value under the active exposure value.
Identification of these effects has been somewhat controversial as it requires assumptions that
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may be overly restrictive for many applications in the health sciences. First, identification invokes
a so-called cross-world-counterfactuals-independence assumption, which by virtue of involving
counterfactuals under conflicting interventions on the exposure, can neither be enforced experi-
mentally nor tested empirically (Robins and Richardson, 2010). Secondly, a necessary assumption
for identification rules out the presence of exposure-induced confounding of the mediator’s ef-
fect on the outcome, even if all confounders are observed. While this assumption is in principle
testable provided no unmeasured confounding, more often than not, post-exposure covariates are
altogether ignored in routine application, in which case mediation analyses may be invalid. These
issues have recently been considered, and some work has been done on partial or point identifica-
tion under a weaker assumption. Specifically, on the one hand Robins and Richardson (2010) and
Tchetgen Tchetgen and VanderWeele (2012) provide conditions for point identification of the pure
direct effect when a confounder is directly affected by the exposure. On the other hand, Robins
and Richardson (2010) give bounds for the pure direct effect for binary mediator without mak-
ing the cross-world-counterfactual-independence assumptions, but assuming no exposure-induced
confounding of the mediator-outcome relation, and Tchetgen Tchetgen and Phiri (2014) extend
these bounds to account for exposure-induced confounding. We build on this previous work to
provide a number of new nonparametric bounds for the pure direct effects allowing for a poly-
tomous mediator when either (i) exposure-induced confounding is present, or (ii) one does not
assume that cross-world counterfactuals of the mediating and outcome variables are independent,
or (iii) both hold simultaneously.
We apply these bounds to data from the Harvard PEPFAR program in Nigeria, where we eval-
uate the extent to which the effects of antiretroviral therapy on virological failure are mediated by
a patient’s adherence. Results are sensitive to the choice of assumptions made, consequently, we
counsel investigators employing these effects to exercise caution in considering the formula they
use for identification and to explicitly state the assumptions required for them to be valid. Where
assumptions are empirically untestable, they should be argued for on the basis of scientific under-
standing, and ideally the alternative should be explored by employing partial identification bounds
given both here and elsewhere. Sensitivity analyses for ranges of plausible associations between
cross-world counterfactuals remain undeveloped, but would be highly beneficial for practical use
in such situations, and are fertile ground for future work. Our hope is that the work presented here
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A M Y A a˜ M(a˜) m˜ Y (a˜, m˜)
Figure 2.1: (a) The simple mediation directed acyclic graph in a setting with no confounding. (b)
The single-world intervention graph in the setting of (a) that has been intervened on to set A to a˜
andM to m˜.
will inspire deeper consideration and transparency regarding underlying identifying assumptions
in the practice of mediation analysis.
2.2 Preliminaries
By way of introduction, the directed acyclic graph (DAG) displayed in Figure 2.1(a) illustrates the
simplest possible mediation setting, where A is defined to be the exposure taking either baseline
value a⇤ or comparison value a,M is defined to be the (potential) mediator, and Y is defined to be
the outcome. This DAG assumes randomization of the exposure, which for expositional simplicity
we maintain throughout. The graph also encodes no unobserved confounding of the effect of M
on Y . The effect along the path A ! Y is considered direct with respect to M , and the effect
along the path A!M ! Y is considered indirect with respect toM .
We now define counterfactual variables, letting Y (a) denote a subject’s outcome if treatment
A were set, possibly contrary to fact, to a. In the context of mediation, there will also be potential
outcomes for the intermediate variable. CounterfactualsM(a) and Y (m, a) are defined similarly.
In order to link these with the observed data, we adopt the standard set of consistency assumptions
27
that
if A = a, thenM(a) = M with probability one,
if A = a andM = m, then Y (m, a) = Y with probability one, and
if A = a, then Y (a) = Y with probability one.
In terms of counterfactuals, the randomization assumption encoded by the DAG in Figure 2.1(a) is
{Y (a,m),M(a)} ?? A for all a and m; the assumption of no unobserved confounding of M is
Y (a,m) ??M(a) | A for all a andm.
Wemay now define the pure/natural direct effect and natural indirect effect (Robins and Green-
land, 1992; Pearl, 2001). These are expressed in terms of nested counterfactuals, i.e., counterfac-
tual outcomes under an intervention which sets the exposure to a given value, and the mediator to
the value it would have had under a possibly conflicting exposure value. They form the following
decomposition of the average causal effect:
E {Y (a)}  E {Y (a⇤)}
=
total e↵ectz }| {
E [Y {a,M(a)}]  E [Y {a⇤,M(a⇤)}]
=
natural indirect e↵ectz }| {
E [Y {a,M(a)}]  E [Y {a,M(a⇤)}] +
pure direct e↵ectz }| {
E [Y {a,M(a⇤)}]  E [Y {a⇤,M(a⇤)}).
The terms E{Y (a)} and E{Y (a⇤)} are identified under randomization of A. The parameter
 0 ⌘ E[Y {a,M(a⇤)}] would be identified if one were to interpret the DAG in Figure 2.1(a) as
a nonparametric structural equation model with independent errors (NPSEM-IE). Structural equa-
tions provide a nonparametric algebraic interpretation of this DAG corresponding to three equa-
tions, one for each variable in the graph. With each random variable on the graph is associated a
distinct, arbitrary function, denoted g, and a distinct random disturbance, denoted ", each with a
subscript corresponding to its respective random variable. Each variable is generated by its corre-
sponding function, which depends only on all variables that affect it directly (i.e., its parents on the
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graph), and its corresponding random disturbance, as follows:
A = gA("A)
M = gM(A, "M)
Y = gY (A,M, "Y ).
Under particular interventions, these structural equations naturally encode dependencies of coun-
terfactuals. Consider, for example, two interventions, one setting A = a⇤, and another setting
A = a andM = m. The structural equations then become
A = a⇤
M(a⇤) = gM(a⇤, "M)
Y (a⇤) = gY (a⇤,M(a⇤), "Y )
A = a
M(a) = m
Y (a,m) = gY (a,m, "Y ).
This formulation places no restriction on the distribution of counterfactuals. The key assump-
tion of the NPSEM-IE is that the random disturbances are mutually independent. This allows us
to make independence statements regarding counterfactuals under various, possibly-conflicting
interventions. In particular, this model implies that for all m, (i) {M(a), Y (a,m)} ?? A, (ii)
Y (a,m) ?? M | A = a, and (iii) Y (a,m) ?? M(a⇤) | A = a, which in turn suffice for iden-
tification of  0 (Pearl, 2001). Independence statements such as (iii) are known as cross-world
counterfactual statements due to their comparison of interventions that could never occur in the
same world simultaneously. Independence (iii) can be seen to hold under the model by consider-
ing the NPSEM-IE under a specific intervention and noting that the only source of randomness in
Y (a,m) = gY (a,m, "Y ) is "Y and the only source of randomness inM(a⇤) = gM(a⇤, "M) is "M .
Thus, the cross-world-counterfactual-independence statement follows directly from independence
of exogenous disturbances. However, such an independence is neither experimentally verifiable
nor enforcable (Robins and Richardson, 2010).
This issue has been discussed extensively (Robins and Richardson, 2010; Richardson and
Robins, 2013), and in large part motivated the development of the single-world intervention graphs
(SWIGs) of Richardson and Robins (2013). These causal graphs manage to elucidate this issue
by graphically representing the counterfactuals themselves, allowing independence statements of
counterfactuals to be read directly from the graph. Consider the SWIG in Figure 2.1(b). By d-
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A R M Y A a˜ R(a˜) M(a˜) m˜ Y (a˜, m˜)
Figure 2.2: (a) A mediation directed acyclic graph in which R is an exposure-induced confounder.
(b) The single-world intervention graph in the setting of (a) that has been intervened on to set A to
a˜ 2 {a, a⇤} andM to m˜.
separation, it is clear that (i) Y (a0,m) ?? M(a0) for all a0 and m, however under a model corre-
sponding to the SWIG generated by the graph in Figure 2.1(a), no such statement can be made about
Y (a,m) and M(a⇤) when a 6= a⇤. While  0 is not point identified under this model, Robins and
Richardson (2010) provide the following bounds for its partial identification in the setting where
M is binary and independence assumptionsM(a0) ?? A and Y (a0,m) ?? {M(a0), A} hold for all
a0 andm:
max{0, pr(M = 0 | A = a⇤) + E(Y |M = 0, A = a)  1}
+max{0, pr(M = 1 | A = a⇤) + E(Y |M = 1, A = a)  1}
  0 
min{pr(M = 0 | A = a⇤), E(Y |M = 0, A = a)}
+min{pr(M = 1 | A = a⇤), E(Y |M = 1, A = a)}.
In Section 2.2, we extend this result to the setting of a polytomousM .
As previously mentioned, another often-overlooked condition required for identification of
 0 is that there is no confounder of the mediator’s effect on the outcome that is affected by the
exposure. Such a confounder is present in the setting illustrated in the DAG in Figure 2.2(a).
Generally, even under an NPSEM-IE ,  0 will not be identified in this setting. This is readily seen
by considering the following representation under this model given by Robins and Richardson
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(2010):
 0 =
X
r,r⇤
E {E(Y |M,R = r, A = a) | R = r⇤, A = a⇤} pr {R(a) = r, R(a⇤) = r⇤} . (2.1)
Clearly the joint probability term can never be identified from observed data, since we will never
be able to observe R(a) and R(a⇤) for the same individual.
A few conditions for identification have been proposed for binary R and M . Robins and
Richardson (2010) give two. The first is that R(a) ?? R(a⇤), in which case the troublesome term
in (2.1) will factor, giving
 0 =
X
r⇤,r
E {E(Y |M,R = r, A = a) | R = r⇤, A = a⇤} pr(R = r⇤ | A = a⇤)
⇥ pr(R = r | A = a).
It seems unlikely, however, that in a scenario in which A affects R, the counterfacual R under
A = a would not be predictive of the counterfactual R under A = a⇤. The other condition
is that the counterfactual outcome under one exposure value is a deterministic function of the
counterfactual for the other treatment, i.e., R(a) = g{R(a⇤)}. In this case,
 0 =
X
r⇤,r
E {E(Y |M,R = r, A = a) | R = r⇤, A = a⇤} pr(R = r⇤ | A = a⇤)I{r = g(r⇤)}.
The above assumption is implied by rank preservation (Robins and Richardson, 2010), which is
unlikely to hold in most social and health sciences as it rules out individual-level effect heterogene-
ity (Tchetgen Tchetgen and VanderWeele, 2012). As none of these conditions are experimentally
verifiable, the authors themselves “do not advocate blithely adopting such assumptions in order to
preserve identification of the PDE in [this setting]" (Robins and Richardson, 2010).
Tchetgen Tchetgen and VanderWeele (2012) give two testable conditions for identification of
 0 when R is present. The first is of A–R monotonicity, i.e., for Bernoulli R, R(a)   R(a⇤). If R
is a vector of Bernoulli random variables whose structural equations have independent errors, and
if monotonicity holds for each element,
 0 =
X
r,r⇤
E {E(Y |M,R = r, A = a) | R = r⇤, A = a⇤}
kY
j=1
fj(rj, r
⇤
j , a, a
⇤)
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where
fj(rj, r
⇤
j , a, a
⇤) =
8>><>>:
pr(Rj = 1 | A = a⇤) if r⇤j = rj = 1,
pr(Rj = 1 | A = a)  pr(Rj = 1 | A = a⇤) if r⇤j = 0 and rj = 1,
0 if r⇤j = 1 and rj = 0,
pr(Rj = 0 | A = a) if r⇤j = rj = 0.
Their second condition is noM–R additive mean interaction, i.e.,
E(Y | m, r, a)  E(Y | m⇤, r, a)  E(Y | m, r⇤, a) + E(Y | m⇤, r⇤, a) = 0,
for all levelsm andm⇤ ofM and r and r⇤ of R. For discreteM and R, this yields
 0 =
X
m
{E(Y | m, r⇤, a)  E(Y | m⇤, r⇤, a)} pr(M = m | A = a⇤)
+
X
r
{E(Y | m⇤, r, a)  E(Y | m⇤, r⇤, a)} pr(R = r | A = a)
+ E(Y | m⇤, r⇤, a).
Eschewing the cross-world-counterfactual assumptions of the NPSEM-IE , Tchetgen Tchetgen
and Phiri (2014) extend the bounds of Robins and Richardson (2010) to allow for the presence of
an exposure-induced confounder when the mediator is binary:
max
(
0, pr(M = 0 | A = a⇤) +
X
r
E(Y |M = 0, R = r, A = a)pr(R = r | A = a)  1
)
+max
(
0, pr(M = 1 | A = a⇤) +
X
r
E(Y |M = 1, R = r, A = a)pr(R = r | A = a)  1
)
  0 
min
(
pr(M = 0 | A = a⇤),
X
r
E(Y |M = 0, R = r, A = a)pr(R = r | A = a)
)
+min
(
pr(M = 1 | A = a⇤),
X
r
E(Y |M = 1, R = r, A = a)pr(R = r | A = a)
)
.
We extend these bounds as well to allow for polytomousM in Section 2.3. Additionally, we con-
struct bounds for  0 under an NPSEM-IE that account for a discrete exposure-induced confounder,
but require no further assumption.
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2.3 New partial identification results
We begin by extending the bounds of Robins and Richardson (2010) and Tchetgen Tchetgen and
Phiri (2014) to settings with discrete mediator and outcome.
Theorem 2.1. Under a model corresponding to the SWIG in either Figure 2.1(b) or Figure 2.2(b)
with discreteM and Y and arbitrary R,X
m,y
y (max [0, pr{M(a⇤) = m}+ pr{Y (a,m) = y}  1] I(y > 0)
+min [pr{M(a⇤) = m}, pr{Y (a,m) = y}] I(y < 0))
  0 X
m,y
y (max [0, pr{M(a⇤) = m}+ pr{Y (a,m) = y}  1] I(y < 0)
+min [pr{M(a⇤) = m}, pr{Y (a,m) = y}] I(y > 0)) .
The upper and lower bounds coincide when Y (a,m) or M(a⇤) is degenerate, which fol-
lows from the properties of joint probability mass functions. The upper bound is achieved
only if Y (a,m) and M(a⇤) are comonotone for each m, i.e., if FY (a,m),M(a⇤)(y,m) =
min
⇥
FY (a,m)(y), FM(a⇤)(m)
⇤
for each m; the lower bound is achieved only if they are counter-
monotone for each m, i.e., if FY (a,m),M(a⇤)(y,m) = max
 
0, FY (a,m)(y) + FM(a⇤)(m)  1
 
for
each m. A straightforward application of the g-formula under the DAGs in Figures 2.1(a) and
2.2(a) yields the following corollaries:
Corollary 2.2. For polytomousM and Y ,  0 is partially identified under the model corresponding
to the SWIG in Figure 2.1(b) by the bounds in Theorem 2.1 with pr{M(a⇤) = m} = pr(M =
m | a⇤) and pr{Y (a,m) = y} = pr(Y = y | m, a). It is partially identified under the model
corresponding to the SWIG in Figure 2.2(b) by the same bounds, but with pr{M(a⇤) = m} =
pr(M = m | a⇤) and pr{Y (a,m) = y} = Pr pr(Y = y | m, r, a)pr(R = r | a).
The second part of the corollary continues to hold even if there were a hidden common cause
of R and Y as in Figure 2.3, since the same g-formula applies in this setting. Whereas the previous
results invoked no cross-world-counterfactual independences under the SWIG interpretation of the
DAG in Figure 2.2(a), sharper bounds are available under Pearl’s NPSEM-IE interpretation of these
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A R M Y
H
A a˜ R(a˜) M(a˜) m˜ Y (a˜, m˜)
H
Figure 2.3: (a) A mediation directed acyclic graph in which an unobserved variable H affects R,
an exposure-induced confounder, and Y . (b) The single-world intervention graph in the setting of
(a) that has been intervened on to set A to a˜ 2 {a, a⇤} andM to m˜.
DAGs, as derived in the following result.
Theorem 2.3. For discrete R taking values in {1, . . . , p}, let B be the p2 ⇥ (p  1)2 matrix2666666666666666664
Ip 1 0(p 1)⇥(p 1) · · · 0(p 1)⇥(p 1) 0(p 1)⇥(p 1)
 1Tp 1 0Tp 1 · · · 0Tp 1 0Tp 1
0(p 1)⇥(p 1) Ip 1 · · · 0(p 1)⇥(p 1) 0(p 1)⇥(p 1)
0Tp 1  1Tp 1 · · · 0Tp 1 0Tp 1
...
... . . .
...
...
0(p 1)⇥(p 1) 0(p 1)⇥(p 1) · · · Ip 1 0(p 1)⇥(p 1)
0Tp 1 0
T
p 1 · · ·  1Tp 1 0Tp 1
0(p 1)⇥(p 1) 0(p 1)⇥(p 1) · · · 0(p 1)⇥(p 1) Ip 1
0Tp 1 0
T
p 1 · · · 0Tp 1  1Tp 1
 Ip 1  Ip 1 · · ·  Ip 1  Ip 1
1T(p 1)2
3777777777777777775
,
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d be the p2-dimensional vector266666666666666666664
0p 1
pr (R = 1 | A = a)
0p 1
pr (R = 2 | A = a)
...
0p 1
pr (R = p  1 | A = a)
pr (R = 1 | A = a⇤)
pr (R = 2 | A = a⇤)
...
pr (R = p  1 | A = a⇤)
pr (R = p | A = a) + pr (R = p | A = a⇤)  1
377777777777777777775
,
and x be the vectorization of the matrix [E {E(Y |M,R = r, A = a) | R = r⇤, A = a⇤}]r,r⇤ . Un-
der a NPSEM-IE corresponding to the DAG in Figure 2.2(a) where M and Y can be either con-
tinuous or discrete,  0 is partially identified by
⇥
xT (B L + d), xT (B U + d)
⇤
, where  L and  U
are the minimizing and maximizing solutions respectively to the linear programming problem with
objective function xTB  subject to the constraints

I(p 1)2
 I(p 1)2
 
  
26666666666666664
min{pr(R = 1 | A = a), pr(R = 1 | A = a⇤)}
min{pr(R = 1 | A = a), pr(R = 2 | A = a⇤)}
...
min{pr(R = p | A = a), pr(R = p  1 | A = a⇤)}
min{pr(R = p | A = a), pr(R = p | A = a⇤)}
1  pr(R = 1 | A = a)  pr(R = 1 | A = a⇤)
1  pr(R = 1 | A = a)  pr(R = 2 | A = a⇤)
...
1  pr(R = p | A = a)  pr(R = p  1 | A = a⇤)
1  pr(R = p | A = a)  pr(R = p | A = a⇤)
37777777777777775
and     0.
Similar to the previous result, these bounds coincide if either R(a) or R(a⇤) is degenerate.
The upper bound is achieved when R(a) and R(a⇤) are comonotone; the lower bound is achieved
when they are countermonotone. While these bounds are not available in closed form, they can be
readily solved using standard software, such as with the lp_solve function, which uses the revised
simplex method and is accessible from a number of languages, including R, MATLAB, Python,
and C. While the method used by this software is not guaranteed to converge at a polynomial
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rate (Klee and Minty, 1970), it is quite efficient in most cases (Schrijver, 1998). The following
corollary shows that these bounds reduce to a closed form when R is binary.
Corollary 2.4. Under a NPSEM-IE corresponding to the DAG in Figure 2.2(a) with binary R,
min
⇡112⇧
X
r,r⇤
E {E(Y |M,R = r, A = a) | R = r⇤, A = a⇤}h(r, r⇤, ⇡11)
  0 
max
⇡112⇧
X
r,r⇤
E {E(Y |M,R = r, A = a) | R = r⇤, A = a⇤}h(r, r⇤, ⇡11)
where ⇧ is the set
{max {0, pr(R = 1 | A = a) + pr(R = 1 | A = a⇤)  1} ,
min {pr(R = 1 | A = a), pr(R = 1 | A = a⇤)}}
and
h(r, r⇤, ⇡11) =
8>><>>:
⇡11 if r⇤ = r = 1,
pr(R = 1 | A = a)  ⇡11 if r⇤ = 0 and r = 1,
pr(R = 1 | A = a⇤)  ⇡11 if r⇤ = 1 and r = 0,
1  pr(R = 1 | A = a)  pr(R = 1 | A = a⇤) + ⇡11 if r⇤ = r = 0.
Under A R monotonicity with binary R, the identifying functional given by Tchetgen Tch-
etgen and VanderWeele (2012) is recovered at the upper bound in Corollary 2.4. All results given
here can be extended to settings with observed pre-exposure confounders, which we denote C.
In Corollary 2.2, one must first perform conditional inference given C, then subsequently average
over the conditional bounds. This is in fact valid due to Jensen’s inequality, because the constraints
on the marginal joint probabilities are already implied by the constraints enforced on the condi-
tional joint distributions, so no further constraints need be considered. Jensen’s inequality does not
apply in the case of Theorem 2.3, however, so controlling for C requires estimating two pairs of
candidate bounds and selecting the larger of the lower bounds and the smaller of the upper bounds.
When p is of moderate size,   can be solved for each covariate pattern of C, i.e., without modeling
the dependence of the cross-world-counterfactual joint distribution on C. Averaging the resulting
conditional bounds gives the first pair of bounds. The second pair results from replacing each
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probability in the theorem with an average over the probabilities conditional on C and doing the
same with x.
2.4 Application to Harvard PEPFAR data set
We now consider an application to a data set collected by the Harvard President’s Emergency Plan
for AIDS Relief (PEPFAR) program in Nigeria. The data set consists of previously antiretroviral
therapy (ART)-naïve, HIV-1 infected adult patients who began ART in the program and were
followed at least one year following initiation. Patients without reliable viral load data at two of
the hospitals were excluded. Only complete cases initially assigned to either TDF+3TC/FTC+NVP
or AZT+3TC+NVP1 were considered for this analysis. Thus, the data set we consider consists of
6627 patients, 1919 of whom were assigned to TDF+3TC/FTC+NVP, and the remaining 4708
assigned to AZT+3TC+NVP.
There has accumulated evidence of a differential effect on virologic failure (defined by the
World Health Organization as repeat viral load above 1000 copies/mL after 6 months of ART du-
ration) between these two first-line antiretroviral treatment regimens (Tang et al., 2012). A natural
question of scientific interest is what role adherence plays in mediating this differential effect. We
are primarily interested in learning about the scientific mechanism of this effect on the individual
level. The natural indirect effect best captures this mechanism in that it captures an isolated effect
difference mediated by adherence by, in a sense, deactivating effect differences along all other pos-
sible causal pathways. We specifically examine the effect through adherence over the second six
months since treatment assignment, i.e., the six months prior to the first viral load measurement.
Identification is complicated by the presence of treatment toxicity, which clearly affects adher-
ence directly, and has the potential to modify the effect of the treatment assignment on virologic
failure. Thus, toxicity measured at six months after treatment assignment is an exposure-induced
confounder of the effect of the mediator on the outcome. Further, toxicity and virologic failure
are likely to be rendered dependent by unobserved underlying biological common causes as in
Figure 2.3, where H represents these hidden biological mechanisms. Because we define the me-
diator to be adherence over the second six months, adherence over the first six months is also an
13TC=lamivudine, AZT=zidovudine, FTC=emtricitabine, NVP=nevirapine, TDF=tenofovir
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exposure-induced confounder along with toxicity, and must be accounted for. Had we defined the
mediator to be adherence over the full year, measurement of the mediator and toxicity would have
overlapped, violating the principle of temporal ordering.
Let C denote the vector consisting of baseline covariates sex, age, marital status, WHO stage,
hepatitis C virus, hepatitis B virus, CD4 count, and viral load. Let A be an indicator of ART
assignment taking levels a⇤ for TDF+3TC/FTC+NVP and a for AZT+3TC+NVP; R be a vector
of two indicator variables, one of the presence of any lab toxicity, and one of adherence exceeding
95%, both over the first six months following initiation of therapy;M be an indicator of adherence
exceeding 95% over the subsequent six months; and Y be an indicator of virologic failure at one
year, i.e., repeat viral load above 1000 copies/mL at one year and at 18 months.
Here we estimate the natural indirect effect of A on Y through M , as defined above, on the
risk difference scale using the various sets of identifying assumptions given above. Throughout,
inference is performed using maximum likelihood for point estimation and a randomly weighted
bootstrap (Rao and Zhao, 1992; Van Der Vaart and Wellner, 1996) for confidence intervals due to
the rarity of the outcome. The results are summarized in Figure 2.4. It is immediately apparent
that inference is remarkably sensitive to which identifying assumptions are made. Consider an
investigator who is willing to rely on cross-world-counterfactual independences. If she decides
to ignore the presence of toxicity, she will conclude that there is a very small, yet significant
negative indirect effect. Conversely, if she makes the no M–R interaction assumption, she will
find a significant positive indirect effect with considerable uncertainty. In fact, an empirical test
of this assumption reveals that it is unlikely to apply. Similarly, another empirical test suggests
the assumption of independent errors of the components of R needed for the identifying functional
under monotonicity to be valid is also unlikely to hold. Nonetheless, we present both results for the
sake of comparison. Results are fairly imprecise under monotonicity, and do not show a significant
effect.
Another investigator unwilling to impose cross-world-counterfactual-independence assump-
tions is left with little to say as the bounds are uninformative, regardless of how toxicity is handled.
Interestingly, the bounds that result from making no assumptions about the joint distribution of the
cross-world R counterfactuals are narrower than the bounds that result from ignoring R. That is,
the bounds themselves appear narrower; the variances of the interval estimates appear to be com-
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Figure 2.4: A plot showing the estimated natural indirect effect of ART assignment on virologic
failure with respect to adherence under the various assumptions. The assumptions vary across the
horizontal axis, with the first part of the label indicating the assumption regarding the exposure-
induced confounder, R, and the second part indicating the assumption regarding cross-world coun-
terfactuals. For the assumptions regarding R, “Ignore" means that the presence of R is ignored al-
together, “Monoton." means the A–R monotonicity assumption in Section 2.1, “No M*R" means
the no M–R interaction assumption in Section 2.1, and “None" means that R was accounted
for without additional assumptions. For the assumptions regarding cross-world counterfactuals,
“IE" means a NPSEM-IE was assumed, and “None" means no cross-world-counterfactuals inde-
pendences were assumed. When the assumptions give partial identification, the two dots represent
the point estimates of the upper and lower bound for the natural indirect effect, and the vertical
bar represents the bootstrap 95% confidence interval for the interval. When the assumptions give
full identification, the single dot represents the point estimate of the natural indirect effect, and the
vertical bar represents its bootstrap 95% confidence interval.
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Figure 2.4: (Continued)
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parable. This is because even though we do not impose any restrictions on the distribution of R or
its counterfactuals a priori, observing R is clearly informative. The bounds accounting for R have
the added advantage of being the only identifying formula that remains valid when toxicity and
virologic suppression are affected by an unobserved common cause, as in Figure 2.3.
Finally, incorporating R results in narrower interval estimates than not imposing the inde-
pendence assumption even if R were ignored. Thus, cross-world-counterfactual-independences
appear to have stronger empirical implications in the current analysis than assumptions regarding
exposure-induced confounders. The general trend in these results is that little is gained in terms
of precision by assumptions regarding R. In fact, the confidence interval for the bounds resulting
from the independent errors assumption and no assumption regarding R is narrower than the con-
fidence interval for the estimate that results from assuming monotonicity, despite the fact that the
NIE is point-identified in the latter case. The naïve assumption that R is not a confounder is the
only assumption about R under which precision is gained.
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A Class of Semiparametric Tests of Treatment Effect Robust to
Measurement Error of a Confounder
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3.1 Introduction
In observational studies across an array of disciplines, it is not uncommon to observe variables X
measured with error. As noted in Cote and Buckley (1987), “Campbell (1969) has gone so far as to
say that measurement error (both random error and method effect) and its confounding influences
on research findings cannot be avoided.” In the field of causal inference, data on covariates are
needed to adjust for confounding in order to make inferences with causal interpretations. While a
commonly-cited result states that under relatively-simple settings, the ordinary least squares (OLS)
coefficient estimate of a single variable measured with error in a multiple linear regression will
merely be attenuated to the null, and hence produce a valid (if conservative) hypothesis test of
association, the effects of confounders measured with error can be more harmful. Unaccounted
for, measurement error of confounders will produce biased effect estimates and invalid hypothesis
tests in even the simplest of settings; a multiple linear regression of outcome Y on exposure A and
confounders C and X – where the true confounder X⇤ is measured with classical, nondifferential
error "⇤ such that X = X⇤ + "⇤ – will produce a treatment effect estimate that is biased towards
the crude (unadjusted) estimate. Consequently, any hypothesis test based on this regression will
likely be invalid.
Though there has been tremendous interest in methodology accounting for confounders mea-
sured with error, previous research has largely focused on the case of misclassification of discrete
confounders. In particular, Greenland (1980) conjectured that misclassification of a confounder
results in a “partial” loss of control for confounding, in the sense that the average causal effect will
be biased in the direction of the crude (unadjusted) estimate, but bound between this value and
the truth. This was generally accepted as true (Fung and Howe, 1984; Kaldor and Clayton, 1985;
Tzonou et al., 1985; Kelsey, 1996; Espeland and Hui, 1987) until shown by Ogburn and Vander-
Weele (2012) not to hold in general. The authors showed that this would hold in all-scalar-, binary-
variable settings when there is no qualitative interaction between exposure and confounder. Og-
burn and Vanderweele (2013) extended these conditions to settings with a polytomous confounder.
Less attention has been given to the effect of measurement error on continuous confounders. Using
parametric models, Cochran and Rubin (1973) gave an expression characterizing the bias incurred
by such error that, under simplifying assumptions, allows for a correction provided the reliability
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ratio is known. Battistin and Chesher (2014) generalized this work to nonparametric models using
a first-order approximation of bias for small measurement error (valid for a reliability ratio up to
70%) developed in Chesher (1991). This generalization allows for identification of the average
causal treatment effect and the effect of treatment on the treated for a known measurement-error
variance, or for sensitivity analysis by varying the measurement-error variance across a range of
plausible values. Little else has been published since Cochran and Rubin (1973) on measurement
error of a continuous confounder. Indeed, Battistin and Chesher (2014) claimed this work to be
“to the best of [their] knowledge the only paper to study covariate measurement error within a
programme evaluation [i.e., causal inference] context.”
The method presented by Battistin and Chesher (2014) fits into a more general body of mea-
surement error research that accounts for error without relying on external information. While
most traditional measurement-error-adjustment methods depend on auxiliary data such as instru-
mental variables or data from reliability or validation studies, attention has more recently shifted
to developing methods not depending on such data, which can be expensive to collect or simply
unavailable. One such class of methods uses “higher-order” moment restrictions to produce identi-
fying estimating equations for parameters from the deterministic component of a regression model
with covariates measured with error. Such identifying moment restrictions are implied by the as-
sumption of mutual independence between the error-free covariates, the measurement error, and
the residuals, which can often be justifiable. The setting in which the regression model is linear
in its covariates has been well studied (Kapteyn and Wansbeek, 1983; Stuart and Kendall, 1979;
Pal, 1980; Cragg, 1997; Dagenais and Dagenais, 1997; Lewbel, 1997; Erickson and Whited, 2000,
2002; Lewbel, 2012; Bonhomme and Robin, 2009, among others), and has been shown to be iden-
tified under simple conditions. Schennach and Hu (2013) showed that under sufficient regularity
conditions, nonlinear regression models are nonparametrically identified outside of a particular
parametric class depending on four parameters.
Another method free of external information, known as deconvolution, couples knowledge
of the measurement-error distribution and a kernel estimator of an error-ridden variable to, in a
sense, “cancel out” the measurement error and recover the density of the error-free variable. Fan
(1991) showed that under certain smoothness conditions, convolution density estimates will have
convergence rates of n ⌘ for some ⌘ > 0. Fan and Truong (1993) extended this technique to
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nonparametric regression. Despite this, convergence rates often tend to be too slow for practical
use. Furthermore, though the idea of convolution is attractive in principle, it is very rare that the
distribution of measurement error will be known in practice.
When conditions for point identification are not met, it can be possible to compute bounds
within which the parameter of interest is partially identified. Frisch (1934) first explored this sub-
ject, giving bounds in the simple linear regression case, which Klepper and Leamer (1984) later
extended to multivariable linear regression with all covariates measured with error. Set identi-
fication is more challenging in nonlinear regression models, in that it is not available in closed
form. Schennach (2014) proposed a simulation-based method (ELVIS) for partial identification
for a class of latent-variable models that contains the nonlinear regression model with covariate
measurement error as a special case. Carroll et al. (2006) and Schennach (2012) give surveys of
measurement error methodology containing a more thorough treatment of methods not requiring
external information.
This paper contributes to both the literature on confounder measurement error as well as on
measurement error methods not requiring external information. We present a large class of valid
test statistics of the null hypothesis of no average causal effect when a set of continuous con-
founders are measured with classical, nondifferential error. This class of test statistics is of interest
in a variety of practical settings in that they require neither knowledge of the distribution or vari-
ance of the measurement error (as in Battistin and Chesher (2014) or in deconvolution), nor any
form of external information. We will assume that the measurement error is independent of the
error-free confounders and all other observed variables. Otherwise, no other moment restrictions
are required that are not already embedded in the assumptions needed to draw causal inferences
in the absence of measurement error. In particular, we leverage the no-unobserved-confounding
assumptions needed for identification of the average causal effect.
The governing idea of the proposed approach is that under the null hypothesis of no effect
of exposure, the assumption of no unobserved confounding renders the outcome an instrumental
variable (IV) for the association between the true error-prone covariate X⇤ and A adjusting for
C. Thus, as documented in the literature on IV methods for measurement error, Y can be used to
obtain a consistent estimator of the association between (C,X⇤) andA (Amemiya, 1985; Amemiya
et al., 1990; Amemiya, 1990; Carroll and Stefanski, 1994; Stefanski and Buzas, 1995; Buzas and
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Stefanski, 1996; Carroll et al., 2006; Fuller, 2009, among others). In this paper, we show that
estimation of the conditional association between the error-prone covariates and exposure can be
accomplished jointly with a test of no treatment effect under a unifying framework of a generalized
method of moments test based on overidentifying moment restrictions, known in the econometrics
literature as a Sargan test (Sargan, 1958), Hansen test, or J-test (Hansen, 1982).
Our class of test statistics includes semiparametric tests with nominal type I error rate, if under
the null hypothesis of no treatment effect, (1) the conditional association between the mismeasured
covariates and exposure is linear (on the additive, multiplicative or logit scale) given error-free
confounders, and either (2.a) the association between error-free confounders and exposure given
the true error-prone confounders is correctly specified or (2.b) the association between the outcome
and error-free covariates is correctly specified. Included in this class are tests that are doubly robust
in the sense that they preserve nominal type I error rate if at least one of (2.a) or (2.b) holds, and
it need not be known which conditions holds. Validity of the robust propensity-score tests and
doubly-robust tests is demonstrated via simulation studies. We conclude with a data application in
which we test for a causal effect of same-day temperature on mortality in the United States. We
conduct a multi-city analysis with daily information on mortality as well as environmental factors
including temperature and concentration of particulate matter with diameter of 2.5 micrometres or
less (PM2.5). PM2.5 is known to be a confounder and to be measured with error due to the high
level of variability of pollution across monitoring stations (Armstrong, 1990; Zeger et al., 2000;
Armstrong, 2004; Bateson et al., 2007; Kioumourtzoglou et al., 2014). We apply our method to
test for this effect, controlling for seasonal trends and PM2.5 for confounding while accounting for
the measurement error of the latter.
3.2 A class of propensity-score-based test statistics robust to
measurement error
To formalize discussion, we define for each a the counterfactual Ya to be a subject’s outcome had
the subject been assigned, possibly contrary to fact, to exposure level a. We link these counterfac-
tuals to the observed variables via the consistency assumption (Robins, 1986), which states that if
A = a, then Ya = Y with probability one for each level a. We assume the observed covariates X
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are measured with classical error, i.e., additive independent measurement error, and are related to
their corresponding, unobserved, true value X⇤ by X = X⇤ + "⇤, where "⇤ is the measurement
error, assumed to be independent of X⇤, C, A, and Y . Suppose that in addition to X⇤, a set of
error-free confounders C are also observed. Further, suppose the following holds:
Assumption 3.1. Ya ?? A | C,X⇤ for each level a (No unmeasured confounding).
In the following developments, suppose that A is continuous; results are generalized to binary and
count exposure in Section 3.8. We now present a class of test statistics for the null hypothesis
H0 : E(Ya | C,X⇤) = E(Y0 | C,X⇤) for all a.
Intuitively, under the sharp null, the assumption of no unmeasured confounding implies that
A ?? Y | C,X⇤. (3.1)
Furthermore since X⇤ is a confounder, we have that
Y 6?? X⇤ | C. (3.2)
Statements 3.1 and 3.2 formally define Y as an instrumental variable for the conditional association
between X⇤ and A given C (Carroll et al., 2006). Although H0 is weaker than the sharp null, this
result continues to hold despite Y no longer formally being an IV.
We present our first result, which relies on correct specification of a mean regression model for
exposure. In this vein, consider the semiparametric modelMA as the set of laws for (A,X⇤, C, Y )
with sole restriction the parametric model
E(A | C,X⇤ = 0) = gA(C;↵1)
E(A | C,X⇤)  E(A | C,X⇤ = 0) = ↵T2X⇤,
where g is a known function of C indexed by ↵1. The unknown parameters ↵1 and ↵2 have
dimensions p1 and p2, respectively. We assume throughout that the X⇤   A association is linear
given C, however gA(C;↵1), though parametric, can be any nonlinear function in C.
Theorem 3.2. Let `(C) andm(C) each be vector-valued functions of C with linearly-independent
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elements and dimension p+ q for some positive integer q, where p = p1 + p2, and let
U(↵) ⌘ {`(C)Y +m(C)} {A  E(A | C,X;↵)},
where E(A | C,X;↵) = gA(C;↵1) + ↵T2X . Further, let ⌦ = E
⇥
U(↵)U(↵)T
⇤
and Uˆn(↵) ⌘
PnUi(↵), where Pn denotes the empirical mean of its argument. If U(↵) is continuously differen-
tiable, r↵E{U(↵)} = E{r↵U(↵)}, and ⌦ 1E{r↵U(↵)} has full rank, then for any ⌦ˆn p ! ⌦,
the test statistic
 2robustA ⌘ min↵ nUˆn(↵)
T ⌦ˆ 1n Uˆn(↵)
d !  2q
underMA and H0.
Thus, we have a valid test which depends on X⇤ only through the mismeasured covariate, X .
Intuitively, the standard normal equations for coefficients in the propensity-score model incur bias
due to the components that are the product of the residual with the error-prone covariate. However,
this can be amended by replacing these components with the product of the residual with Y , since
under H0, this product forms an unbiased estimating equation. More such unbiased estimating
equations can be added simply by multiplying his product by functions of C, and hence these can
be used to form a valid Sargan test statistic. Thus, a simple form of the test in Theorem 3.2 with
q = 1 could user↵1gA(C;↵) augmented by Y and the product of Y with an element of C in place
of `(C)Y + m(C), for instance. The following iterative procedure can be used to compute the
variance-estimate component ⌦ˆn:
initialize ↵˜ := argmin
↵
Uˆn(↵)T Uˆn(↵);
set ⌦ˆn := Pn
⇥
U(↵˜)U(↵˜)T
⇤
;
do
set ↵˜ := argmin
↵
Uˆn(↵)T ⌦ˆ 1n Uˆn(↵);
set ⌦ˆn := Pn
⇥
U(↵˜)U(↵˜)T
⇤
;
while convergence not reached;
The first two steps are in fact sufficient for asymptotic validity, however iterating generally
improves finite-sample performance. Alternatively, a continuous updating approach can be used,
in which ⌦ˆn is indexed by ↵, and nUˆn(↵)T ⌦ˆn(↵) 1Uˆn(↵) is minimized in ↵ through both Uˆn(↵)
and ⌦ˆn(↵). Next we illustrate the behavior of the proposed test statistic via a simulation study.
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3.3 A simulation study of the test statistic  2robustA
We now present hypothesis testing results from a simulation study drawing samples from the fol-
lowing data generating mechanism. We generate (Y0, C) under a joint normal model given by
Y0 = N(0, 1)
C = Y0 +N(0, 1),
and X⇤ and A under
X⇤ = Y0 + C + Y0C +N(0, 1)
A = C +X⇤ +N(0, 4).
To reflect the sharp null hypothesis, we let Y = Y0. We generateX from the classical measurement
error model
X = X⇤ +N(0, 9[1/⌧   1]),
where ⌧ is the reliability ratio, i.e., the ratio of the variability of the correctly-measured variable
X⇤ to the variable measured with error X . One may easily verify that Assumption 3.1 and H0 are
satisfied.
Samples were repeatedly drawn under twelve different settings: with sample sizes of 1000,
5000, and 10,000, each with reliability ratios of 50%, 70%, 90%, and 100% (i.e., no measurement
error). In each setting, we applied the simple form of the testing procedure described in Section
3.2, using a Gram-Schmidt orthonormalization of [1, C, C2, C3] for the function `(C),m(C) = 0,
gA(C;↵1) = ↵1C, and q = 1. We compared this test with two others that ignored the presence of
measurement error. The first was a robust outcome-regression test, using the p-value of the regres-
sion coefficient for A when regressing Y on C, X , and A and using a sandwich variance estimate.
Though this model is not correctly specified, the OLS estimate of the coefficient for A in the ab-
sence of measurement error will be unbiased for the slope of A in E(Y | A,C,X⇤) (zero). This
is because it is equal to the OLS estimate of the coefficient for the residual obtained from a linear
regression ofA on C andX⇤, which happens to be correctly specified. The second comparison test
was a g-estimation test (Robins, 1989), using the p-value of the regression coefficient for Y when
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regressing A on C, X , and Y . All tests used an ↵ level of 0.05. To demonstrate the validity of our
test, we conducted all tests on 100,000 samples per setting. The results are presented in Table 3.1.
Table 3.1: Estimated type I error rate from 100,000 hypothesis tests simulated under the null
hypothesis
n Rel. ratio (%) Robust PS G-estimation Standard OR
1000 50 0.0604 1.000 1.000
70 0.0444 0.989 0.985
90 0.0431 0.493 0.485
100 0.0447 0.0511 0.0508
5000 50 0.0485 1 1
70 0.0482 1 1
90 0.0485 0.991 0.991
100 0.0491 0.0496 0.0494
10,000 50 0.0493 1 1
70 0.0495 1 1
90 0.0501 1.000 1.000
100 0.0497 0.0500 0.0498
This simulation clearly demonstrates that the standard OLS and g-estimation tests had
approximately-correct type I error rates only in the absence of measurement error. In contrast,
the proposed test statistic was found to have correct type I error rate across all settings considered,
with improved performance with increasing sample size. There was no discernable trend between
estimated type I error rates and reliability ratios for the robust test.
3.4 A class of doubly-robust test statistics
Validity of the test given in Section 3.2 relies on correct specification of gA(C;↵1), however this
model may be misspecified, thus it is of interest to explore an alternative, potentially more robust
approach. Here we present a large class of doubly-robust test statistics. In order to describe this
class of statistics, let E(Y | C;  ) = gY (C;  ), and consider the semiparametric modelMY with
sole restrictions
E(A | C,X⇤)  E(A | C,X⇤ = 0) = ↵T2X⇤
E(Y | C) = gY (C;  ).
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This is a semiparametric model since the association between C and A given X⇤ = 0 is un-
restricted. Further consider the union model M[ ⌘ MA [MY . We present a class of test
statistics for each of these two models, adopting the notation  A(↵) ⌘ A   E(A | C,X;↵) and
 Y ( ) ⌘ Y   E(Y | C;  ) for the residuals in each model.
Theorem 3.3. Let
U(↵,  ) ⌘

k(C) Y ( )(A  ↵T2X)
S( )
 
,
where S( ) is a system of estimating equations for  , k(C) is a vector-valued function of C with
linearly-independent elements with dimension p2 + q for some positive integer q. Suppose U(↵,  )
is continuously differentiable, r↵2, E{U(↵,  )} = E{r↵2, U(↵,  )}, and ⌦ 1E{r↵2, U(↵,  )}
has full rank, where ⌦ = E
⇥
U(↵,  )U(↵,  )T
⇤
. Then under MY and H0,  2robustY ⌘
min
↵2, 
nUˆn(↵,  )T ⌦ˆ 1n Uˆn(↵,  )
d !  2q , for any ⌦ˆn p ! ⌦.
Theorem 3.4. Let
U(↵,  ) ⌘
24 k(C) Y ( ) A(↵){`(C)Y +m(C)} A(↵)
S( )
35 ,
where S( ) is a system of estimating equations for   that is unbiased when gY (C;↵) is correctly
specified, k(C), `(C), andm(C) are each vector-valued functions of C with linearly-independent
elements, and ` and m have dimension p1 and k has dimension p2 + q for some positive integer
q. Suppose U(↵,  ) is continuously differentiable, r↵, E{U(↵,  )} = E{r↵, U(↵,  )}, and
⌦ 1E{r↵, U(↵,  )} has full rank, where ⌦ = E
⇥
U(↵,  )U(↵,  )T
⇤
. Then under M[ and H0,
 2dr ⌘ min↵,  nUˆn(↵,  )
T ⌦ˆ 1n Uˆn(↵,  )
d !  2q , for any ⌦ˆn p ! ⌦.
As before, an appropriate variance estimator ⌦ˆn can be computed using either an iterated pro-
cedure or a continuous-updating approach. An alternative approach would be to first estimate   by
solving PnS( ) = 0, plug this value into U(↵,  ) (rendering the  -estimating-equation component
zero), and use
⌦ˆn =
1
n
nX
i=1
24Ui(↵ˆ,  ˆ)  1
n
nX
j=1
r Uj(↵ˆ,  ) | ˆ
(
1
n
nX
j=1
r Sj( ˆ)
) 1
Si( ˆ)
35⌦2
for the variance estimator in the denominator of the test statistic.
All estimates of ⌦ˆn discussed so far require that k, `, andm have not been estimated. Power for
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both these and the previous tests can be optimized by using appropriate choices of the functions
`(C), m(C), and k(C) based on the direction of the alternative hypothesis, which we discuss
further in Section 3.7.
3.5 A simulation study for double robustness
We now demonstrate the double-robustness property via a simulation study. We drew 100,000
samples of size 5000 from the same data generating mechanism as in Section 3.3, and tested the
same null hypothesis that E(Ya | C,X⇤) = E(Y0 | C,X⇤) for all a using the doubly-robust form
of our test described in the previous section. For comparison, we also include all tests considered in
the previous simulation study of Section 3.3. All tests with the exception of the standard outcome-
regression test (see Table 3.2 footnote) were conducted under three different models: the intersec-
tion model M\, in which both gY (C;  ) and gA(C;↵1) were correctly specified; MY , in which
gY (C;  ) was correctly specified and gA(C;↵1) was not; and MA, in which gA(C;↵1) was cor-
rectly specified and gY (C;  )was not. We used gY (C;  ) =  0+ 1C and gA(C;↵1) = ↵1C for the
Table 3.2: Estimated type 1 error from 100,000 hypothesis tests simulated under the null hypothesis
Model Rel. ratio (%) DR Robust PS G-estimation Standard OR2
M\ 50 0.0455 0.0472 1 1
70 0.0453 0.0482 1 1.000
90 0.0533 0.0484 0.645 0.643
100 0.0476 0.0489 0.0496 0.0493
MY 50 0.0452 0.714 1 1
70 0.0486 0.858 1 1.000
90 0.0527 0.939 1 0.643
100 0.0519 0.958 0.965 0.0493
MA 50 0.0463 0.0472 1 1
70 0.0495 0.0482 1 1.000
90 0.0472 0.0484 0.645 0.643
100 0.0497 0.0489 0.0496 0.0493
2The conditional mean of Y given C and A does not have a simple form, yet the standard outcome-regression test
does not require it to be modeled correctly for validity as described in Section 3.3. Therefore, we show results for the
standard outcome-regression test using the misspecified model described in Section 3.3 in all cases for the purposes of
comparison.
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correctly-specified models and gY (C;  ) =  0 +  1C2 and gA(C;↵1) = ↵1C2 for the incorrectly-
specified models. The index functions for the doubly-robust test used a Gram-Schmidt orthonor-
malization of [1, C, C2, C3], with k(C)T and m(C)T being equal to the first two columns and
`(C)T being equal to the last two. The score equations for   were S( ) = [1, C2]T (Y   0  1C2)
underMA, and S( ) = [1, C]T (Y    0    1C) otherwise. The results are presented in Table 3.2.
As expected, the doubly-robust test was approximately valid with correct Monte Carlo type 1
error rate under all settings. The standard test, on the other hand, was approximately valid under
M\ andMA, but not underMY . As in the previous study, the g-estimation and standard outcome-
regression tests were not valid in the presence of measurement error, and the standard outcome-
regression test was approximately valid in its absence. The g-estimation test was approximately
valid under no measurement error only when gA was correctly specified.
3.6 Application to test for an effect of temperature onmortality
As evidence for climate change continues to accumulate, the natural question of whether temper-
ature affects mortality is of increasing public-health concern. While there are many long-term
threats posed by rising global temperatures, the immediate effects on mortality also pose a grave
public health concern. When studying this effect, it is vital to control for pollution as a potential
confounder (O’Neill et al., 2003). A common metric of pollution is PM2.5 concentration, however
this is well known to be measured with error (Armstrong, 1990; Zeger et al., 2000; Armstrong,
2004; Bateson et al., 2007; Kioumourtzoglou et al., 2014). In particular, PM2.5 is considered
to be contaminated with a mixture of both Berkson error, due to the variability of concentration
actually experienced across individuals, and classical error, due to aggregation of measurements
across multiple monitoring stations (Zeger et al., 2000; Kioumourtzoglou et al., 2014). The former
is benign in the sense that it increases variance but introduces no bias; it is the latter with which
we are most concerned. Some studies have attempted to account for measurement error on PM2.5
using spatial smoothing models (Hoek et al., 2002; Jerrett et al., 2005; Yanosky et al., 2008; Puett
et al., 2009; Szpiro et al., 2010; Sampson et al., 2011), however these rely on geographical data on
residency and may induce other forms of error (Gryparis et al., 2009; Szpiro et al., 2011; Sheppard
et al., 2012). We implemented our method, which does not depend on any collection of extraneous
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data, and compared it against two methods that ignore the presence of measurement error.
The data set used here consists of time-series mortality data from forty-one U.S. cities mea-
sured over the course of 1999 to 2006, though in our analysis, we only considered twenty-four
cities with at least eight deaths per day, as cities with lower mortality rates were unlikely to pro-
vide enough power to detect an effect. Data on individual mortality with exact date of death
was acquired from the National Center for Health Statistics (NCHS) and from state public health
departments (Zanobetti et al., 2009). We excluded accidental deaths (ICD-code 10th revision:
V01-Y98, ICD-code 9th revision: 1-799) and deaths of individuals who did not reside in the city
in which they died. Temperature data were obtained from the National Oceanic and Atmospheric
Administration (NOAA) website, with a city being assigned ambient temperature readings from
its nearest monitoring station. PM2.5 data were obtained from the US Environmental Protection
Agency’s (EPA) Air Quality System (AQS) database (US EPA 2013). PM2.5 readings were aver-
aged over all monitors in a city whenever multiple were available.
On a given day, i, let Yi denote the number of deaths, Ai denote the average temperature in
degrees Celcius,Xi denote the average PM2.5 concentration measurement, and Ci consist of date,
ti, and dummy variables for day of week. Models gA(C;↵) and gY (C;  ) in the propensity-score
and outcome-regression models used both Fourier bases for time with a period of one year to
account for seasonal trends as well as polynomial bases for time to account for secular trends. The
dimensions of the Fourier bases were at least four (not including intercept) and the dimensions of
the polynomial bases started at zero. Sargan goodness-of-fit tests were used to assess model fit,
and more dimensions were added to the bases until the tests no longer rejected at an ↵ level of 0.10.
In particular, we used forms of the test in Theorem 3.2 with `(C) = 0 (eliminating its power to
test for an effect on Y ) andm(C) equal to r↵gA(C;↵) augmented by the next two polynomial or
Fourier basis functions. Analogous tests were used for the robust outcome-regression model, with
the moment functions being equal to the regression residuals multiplied byr gY (C;  ) augmented
by the next two polynomial or Fourier basis functions. Without this step, test rejections could be
attributable to model misspecification rather than the presence of a true effect. Both models were
linear in these terms as well as the day-of-week dummy variables. The robust outcome-regression
model used a log link.
Measurement-error-robust tests from each of the three classes presented in Theorems 3.2-3.4
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were conducted based on these models. For the robust propensity-score test, we used [1, t, 0Tp 1]T as
the function `(C), where 0p 1 is a vector of zeroes with length p 1, and [0, 0,rT↵gA(C;↵)]T as the
functionm(C). For the doubly-robust test, we used [1, t]T as the function k(C), [1,rT↵gA(C;↵)]T
asm(C), and a vector of zeroes with length p1 + 1 as the function `(C). The same index function
k(C) was used for the robust outcome-regression test. Thus, in each case q = 1, and we compared
resulting test statistics with the corresponding null distribution,  21. We used the doubly-robust
test for inference, and supplemented our analysis with the other two for an additional check of
model fit. The two standard statistics – based on the g-estimation and standard outcome-regression
tests – were implemented as in the simulation studies, and used the same gA(C;↵) and gY (C;  )
described above for the robust test statistics, with the addition of a linear term for temperature in the
outcome-regression model. We used OLS to estimate the exposure model for the g-estimation test,
a quasi-Poisson model for the standard outcome-regression test, and sandwich variance estimators
for both.
The doubly-robust test rejected the null hypothesis of no effect of temperature on mortality
in two cities: New York, NY and Stamford, CT. In each case, the robust propensity-score test
also rejected and the robust outcome-regression test did not. In no city did the robust outcome-
regression test reject, suggesting the possibility that it was underpowered. There was no indication
of substantial attenuation due to measurement error for New York, as both standard tests rejected.
For Stamford, on the other hand, it does appear that measurement error may have masked the effect
from the standard tests, as they both failed to reject.
The robust propensity-score test rejected for both Allentown, PA and Philadelphia, PA,
while neither the doubly-robust nor the robust outcome-regression test did, suggesting that the
propensity-score model may not be correctly specified in these cases. Neither of the standard tests
rejected in either of these cities as well, further reducing the credibility of the robust propensity-
score tests’ results for these two cities. In Newark, Salt Lake City, and Washington, one or more
of the standard tests rejected when the robust tests did not. In these cases, we conjecture that the
standard tests were invalidated by the presence of measurement error, and had we not accounted
for it, we would have falsely claimed evidence for an effect in these cities when in fact there was
none.
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Table 3.3: P-values of hypothesis tests for an effect of temperature on mortality in U.S. cities
City Robust PS Robust OR Doubly robust G-estimation Stand. OR
Albuquerque, NM 0.19 0.22 0.20 0.26 0.27
Allentown, PA 0.00096 0.72 0.92 0.26 0.21
Annandale, VA 0.60 0.34 0.79 0.95 0.96
Baltimore, MD 0.93 0.28 0.81 0.95 0.81
Boston, MA 0.39 0.93 0.37 0.051 0.054
Elizabeth, NJ 0.23 0.94 0.58 0.15 0.22
Hartford, CT 0.060 0.25 0.053 0.18 0.17
Lancaster, PA 0.18 0.54 0.17 0.20 0.32
Melville, NY 0.61 0.90 0.18 0.55 0.54
Middlesex, NJ 0.40 0.31 0.18 0.41 0.40
New Haven, CT 0.50 0.24 0.89 0.086 0.12
New York, NY 0.024 0.75 0.000059 0.0035 0.0017
Newark, NJ 0.61 0.41 0.53 0.038 0.053
Paterson, NJ 0.54 0.27 0.30 0.87 0.71
Philadelphia, PA 0.00000038 0.31 0.12 0.49 0.054
Reading, PA 0.52 0.11 0.64 0.29 0.28
Richmond, VA 0.19 0.44 0.28 0.98 0.98
Salt Lake City, UT 0.22 0.43 0.83 0.0048 0.0031
Spokane, WA 0.67 0.68 0.25 0.95 0.96
Stamford, CT 0.044 0.82 0.027 0.79 0.71
Upper Marlboro, MD 0.055 0.37 0.82 0.17 0.079
Washington, DC 0.92 0.85 0.80 0.011 0.014
Wilmington, DE 0.56 0.36 0.87 0.55 0.48
York, PA 0.25 0.83 0.26 0.34 0.35
3.7 Power and estimation under an additive causal model
In this section, we consider estimation and testing under the alternative hypothesis of an additive
causal model,
E[Y0 | A,C,X⇤] = E[Y    0A | A,C,X⇤], (3.3)
where  0 is the average causal effect, i.e., the causal parameter of interest, though the following
discussion can be easily adapted to other structural mean models. We conducted a supplementary
simulation study varying the value of  0 to demonstrate the local power of our proposed test statis-
tics, using the same data generating mechanism as in Section 3.3 in each of the same measurement
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error settings, but with Y = Y0+ 0A to encode the alternative hypothesis. The robust propensity-
score test was conducted on 1000 samples of size 5000 for each value of  0. Results are presented
in Figure 3.1. Additional results for sample sizes of 1000 and 10,000 can be found in the appendix.
As expected, we observed trends of increasing power with effect size and reliability ratio. Also as
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Figure 3.1: Simulation results demonstrating power for n=5000.
expected, power was approximately 0.05 for  0 = 0 in all cases. The test achieved an estimated
80% power at about  0 = 0.06 when ⌧ = 0.5, about  0 = 0.05 when ⌧ = 0.7, about  0 = 0.025
when ⌧ = 0.9, and about  0 = 0.02 when ⌧ = 1. The test’s power appeared to be tending towards
unity in all cases.
Having posited a model for the effect of A on Y , our testing approach can be extended for
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effect estimation. LetH( ) ⌘ Y   A, and defineH ⌘ Y   0A so thatH = H( 0). ThenE(H |
A,C,X⇤) = E(Y0 | A,C,X⇤). Our claim is that it is now that H (instead of Y , since H0 is no
longer assumed) behaves like an instrumental variable for the X⇤ – A association, controlling for
C. To see this, first note that by randomization of A within {C,X⇤}, we have E(H | A,C,X⇤) =
E(Y0 | A,C,X⇤) = E(Y0 | C,X⇤), hence E(H | A,C,X⇤) = E(H | C,X⇤). Secondly, by
assumption, H ?? ✏⇤, and finally, since X⇤ is a confounder of the A–Y association, X⇤ must be
correlated with Y0, and hence H , by definition.
Replacing Y with H( ) in the equations given in Theorems 3.2-4 when q = dim( ) (one,
under model 3.3) produces a system of estimating equations for  , ↵, and (in the doubly-robust
and outcome-regression cases)  . Unbiasedness of these functions follows analogously to the un-
biasedness of the moment equations shown in the proofs for Theorems 3.2-4. Thus, the unknown
parameters can be estimated by solving PnU( ,↵) = 0 or PnU( ,↵,  ) = 0. Under mild reg-
ularity conditions, the resulting estimator will be consistent and asymptotically normal, and the
estimator produced by solving the doubly-robust estimating equations will have these properties
provided at least one of gA(C;↵) or gY (C;  ) is specified correctly.
Optimal choices of functions `(C) and m(C) for the robust propensity-score estimators are
derived in the appendix. These functions also optimize power when used for hypothesis testing in
Section 3.2. We note, however, that these functions depend on parameter estimates from several
additional models, and may not necessarily provide efficiency gain depending on the efficiency of
the nuisance-parameter estimators. The additional variability introduced by these parameters must
be accounted for in finding a suitable variance estimator ⌦ˆn for both testing and estimation. This
can be accomplished (as done with  ) by stacking into U( ,↵,  ) the score or estimating equations
used to estimate the nuisance parameters that estimates of the functions k, `, andm depend on.
3.8 Extensions to binary and count exposures
The test statistics described in this paper can be extended to binary- and count-exposure cases.
Assuming the propensity-score model
logit Pr(A = 1 | C,X⇤) = g(C;↵1) + ↵T2X⇤,
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for binary A or
logE(A | C,X⇤) = g(C;↵1) + ↵T2X⇤,
for count A is correctly specified, we have the following analogous result.
Theorem 3.5. Let `(C) andm(C) each be vector-valued functions of C with linearly-independent
elements and dimension p+ q, where p = p1 + p2, and let
U(↵) ⌘ {`(C)Y +m(C)} exp( ↵T2XA)[A  expit{↵⇤0 + g(C;↵1)}]
if A is binary or
U(↵) ⌘ {`(C)Y +m(C)} [A  exp{↵0 + g(C;↵1) + ↵T2X}]
if A is a count. Suppose U(↵) is continuously differentiable, r↵E{U(↵)} = E{r↵U(↵)}, and
⌦ 1E{r↵U(↵)} has full rank, where⌦ = E
⇥
U(↵)U(↵)T
⇤
. Under H0, the test statistic  2robustA ⌘
min
↵
nUˆn(↵)T ⌦ˆ 1n Uˆn(↵)
d !  2q , for any ⌦ˆn p ! ⌦.
Upon specifying a structural conditional-mean model for the causal effect of A on Y , the
moment functions for these tests can be easily adapted to form estimating equations for the average
causal effect as was shown for the continuous-exposure case.
3.9 Discussion
We have developed a valid test statistic of the sharp null accounting for the presence of a causal
effect when some confounders are contaminated with classical measurement error. This work
contributes to the literature on measurement error not only in causal inference, but also in the
absence of external information by leveraging causal assumptions to produce a function of the
observed data that behaves as an instrumental variable. The tests presented here do not require
a causal model to be specified; they only require specification of a conditional mean model of
the exposure, outcome, or both. The doubly-robust test only requires one of these models to be
correctly specified. The only assumptions required beyond those inherent to the causal inference
framework (e.g., no unobserved confounding) are that the conditional mean of exposure is linear in
the error-prone confounders and that there are no interaction between the error-prone and error-free
confounders.
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Sargan tests behave as goodness-of-fit tests, such that when the appropriate models are cor-
rectly specified, the tests presented here are powered to detect whether H0 fits the data. However,
the tests are also powered to detect model misspecification, so even in the case where there is
no causal effect, the tests will have power to reject. Thus, when our tests reject, it is prudent to
supplement them with a Sargan goodness-of-fit test for each model used as described in Section
3.6 in order to ensure the results are not due to poor model fit. Unfortunately, these tests cannot
distinguish between nonlinearity in C and nonlinearity in X⇤ or interactions between X⇤ and C.
In the multicity application, we tested for an effect of temperature on mortality while account-
ing for confounding by an error-prone measurement of PM2.5, and discovered evidence of an effect
in New York, NY and Stamford, CT. While results from standard tests agreed with our findings
in New York, test results in Stamford disagreed with our results, suggesting these standard tests
were biased toward the null in this case. In three other cities, the standard tests showed evidence of
an effect, while our measurement-error-robust tests did not. This suggested a bias in the standard
tests due to measurement error resulting in false positives, and that our method protected us against
making such an error.
The work presented here is not without limitations. Though the tests presented here are robust
to measurement error of a subset of confounders, at least one true confounder must be measured
correctly. While the doubly-robust test allows for misspecification of the conditional mean of the
exposure in the error-free confounders, it still requires linearity in the error-prone confounders
in the propensity-score model, even when the outcome-regression model is correctly specified.
More importantly, while we have managed to avoid the use of parametric models, the assumptions
of linearity in the error-contaminated confounders and no interaction in the error-contaminated
and error-free confounders on the exposure could be unrealistic in certain settings. In our data
application, no goodness-of-fit test rejected at an ↵ level of 0.10 after adding sufficiently many
basis functions, however we cannot be certain that the goodness-of-fit tests of the final propensity-
score models were powered to detect nonlinearities in the error-contaminated confounders and
interactions in the error-contaminated and error-free confounders. Finally, we did not test for
lagged effects of temperature, which could have some contribution to the effect of temperature on
mortality.
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Appendix A
Proofs and theoretical results for Chapter 1
A.1 Identification Result Proof
Proof of Theorem 1.1.
 0 ⌘ E[Y (M(C1(e0), e),C1(e0), e0)]
=
Z
c0,c1,m,y
ydFY (M(C1(e0),e),C1(e0),e0),M(C1(e0),e),C1(e0),C0(y,m, c1, c0)
=
ZZ
c0,c1,m,y
ydFY (m,e0),M(c1,e),C1(e0)|C0(y,m, c1|c0)dFC0(c0)
=
ZZZ
c0,c1,m,y
ydFY (m,e0),C1(e0)|C0(y, c1|c0)dFM(c1,e)|C0(m|c0)dFC0(c0) (A.1)
=
ZZZ
c0,c1,m,y
ydFY (m,e0),C1(e0)|E,C0(y, c1|e0, c0)dFM(c1,e)|C0(m|c0)dFC0(c0) (A.2)
=
ZZZ
c0,c1,m,y
ydFY (m),C1|E,C0(y, c1|e0, c0)dFM(c1,e)|C0(m|c0)dFC0(c0) (A.3)
=
ZZZZ
c0,c1,m,y
ydFY (m)|C1,E,C0(y|c1, e0, c0)dFM(c1,e)|C0(m|c0)dFC1|E,C0(c1|e0, c0)dFC0(c0)
=
ZZZZ
c0,c1,m,y
ydFY (m)|M,C1,E,C0(y|m, c1, e0, c0)dFM(c1,e)|C1,E,C0(m|c1, e, c0)
⇥ dFC1|E,C0(c1|e0, c0)dFC0(c0) (A.4)
=
ZZZZ
c0,c1,m,y
ydFY |M,C1,E,C0(y|m, c1, e0, c0)dFM |C1,E,C0(m|c1, e, c0)
⇥ dFC1|E,C0(c1|e0, c0)dFC0(c0), (A.5)
where (A.1) follows from {Y (m, e0),C1(e0)} ?? M(c1, e)|C0, (A.2) follows from
{Y (m, e0),C1(e0)} ?? E|C0, (A.3) follows by consistency, (A.4) follows from Y (m) ??
M |C1, E,C0 andM(c1, e) ?? {C1, E}|C0, and (A.5) follows by consistency.
A.2 Derivation of Estimation Strategies
A.2.1 Maximum Likelihood Estimator
The maximum likelihood estimator arises from the alternative representation of (1.1):ZZZ
m,c1,c0
E(Y |m, c1, e0, c0)dFM |C1,E,C0(m|c1, e, c0)dFC1|E,C0(c1|e0, c0)dFC0(c0)
= E(E(E(E(Y |M,C1, e0,C0)|C1, e,C0)|e0,C0)).
We replace the inner three expectations with their arguments’ means under the empirical laws
fˆC1|e0,C0 , fˆM |C1,e,C0 , and fˆY |M,C1,e0,C1 respectively, and compute the empirical mean. Thus, we
have
 ˆmle ⌘ Pn
n
Eˆ(Eˆ(Eˆ(Y |M,C1, e0,C0)|C1, e,C0)|e0,C0)
o
.
A.2.2 Estimator a
 ˆa arises from another alternative representation of (1.1):ZZZ
m,c1,c0
E(Y |m, c1, e0, c0)dFM |C1,E,C0(m|c1, e, c0)dFC1|E,C0(c1|e0, c0)dFC0(c0)
=
X
e⇤2{e0,e}
Z
y,m,c1,c0
y
1e0(e⇤)
f(e0|c0)
f(m|c1, e, c0)
f(m|c1, e⇤, c0)dFY,M,C1,E,C0(y,m, c1, e
⇤, c0)
= E
⇢
Y
1e0(E)
f(e0|C0)
f(M |C1, e,C0)
f(M |C1, e0,C0)
 
.
We simply plug in the empirical laws, fˆE=0|C0 , fˆM |C1,e,C0 , and fˆM |C1,e0,C0 for fE=0|C0 , fM |C1,e,C0 ,
and fM |C1,e0,C0 respectively, and compute the empirical mean. Thus, we have
 ˆa ⌘ Pn
(
Y
1e0(E)
fˆ(e0|C0)
fˆ(M |C1, e,C0)
fˆ(M |C1, e0,C0)
)
.
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A.2.3 Estimator b
 ˆb arises from a third representation of (1.1):ZZZ
m,c1,c0
E(Y |m, c1, e0, c0)dFM |C1,E,C0(m|c1, e, c0)dFC1|E,C0(c1|e0, c0)dFC0(c0)
=
X
e⇤2{e0,e}
Z
m,c1,c0
E(Y |M,C1, e0,C0) 1e(e
⇤)
f(e⇤|c0)
f(c1|e0, c0)
f(c1|e⇤, c0)dFM,C1,E,C0(m, c1, e
⇤, c0)
= E

1e(E)
f(e|C0)
f(C1|e0,C0)
f(C1|e,C0) E(Y |M,C1, e
0,C0)
 
.
Again, we plug in the empirical laws fˆC1|e0,C0 , fˆC1|e,C0 , and fˆE=1|C0 for fC1|e0,C0 , fC1|e,C0 , and
fE=1|C0 , respectively, replace E(Y |M,C1, e0,C0) with Eˆ(Y |M,C1, e0,C0), the expectation of Y
under the empirical law fˆY |M,C1,e0,C0 , and compute the empirical mean. Thus, we have
 ˆb ⌘ Pn
(
1e(E)
fˆ(e|C0)
fˆ(C1|e0,C0)
fˆ(C1|e,C0)
Eˆ(Y |M,C1, e0,C0)
)
.
We develop the multiply-robust estimator and prove its robustness properties in the following two
sections.
A.3 Derivation of the Influence Function
Theorem A.1. The efficient influence function of  0 in modelMnonpar is given by
V eff ( 0) =
1e0(E)f(M |e,C1,C0)
f(M |e0,C1,C0)f(e0|C0) {Y   B(M,C1, e
0,C0)}
+
1e(E)f(C1|e0,C0)
f(C1|e,C0)f(e|C0) {B(M,C1, e
0,C0)  B0(C1, e0, e,C0)}
+
1e0(E)
f(e0|C0) {B
0(C1, e0, e,C0)  B00(e0, e,C0)}+ {B00(e0, e,C0)   0},
implying that the asymptotic variance of a regular, asymptotically linear (RAL) estimator of  0 in
modelMnonpar can be no smaller than E{V eff ( 0)2} 1, the semiparametric efficiency bound for
the model.
 ˆmr is obtained simply by solving the estimating equation V eff ( 0) for  0. Since our model
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is nonparametric, the asymptotic variance is the same for any estimator inMnonpar so long as it is
RAL. Furthermore, since all such estimators share the common influence function V eff ( 0), they
also share a common asymptotic expansion, viz. n1/2( ˆ0    0) = n1/2PnV eff ( 0) + op(1), where
Pn denotes the empirical mean.
Proof. Let ⌫ denote the appropriate dominating measure or product measure corresponding to each
combination of random variables. Let FO;t = FY |M,C,E,C0;tFM |C1,E,C0;tFC1|E,C0;tFE|C0;tFC0;t
denote a one-dimensional regular parametric submodel ofMnonpar with FO,0 = FO, and let
 t =  0(FO;t) = Et(Y (M(e,C1(e0)),C1(e0), e0))
=
Z
m,c1,c0
Et(Y |m, c1, e0, c0)ft(M = m|c1, e, c0)ft(C1 = c1|e0, c0)ft(C0 = c0)d⌫(m, c1, c0)
and UO = Ot=0ft(O)f(O) be the score forO. Then
@ t
@t
    
t=0
=Z
m,c1,c0
Ot=0Et(Y |m, c1, e0, c0)f(M = m|c1, e, c0)f(C1 = c1|e0, c0)f(C0 = c0)d⌫(m, c1, c0)
(A.6)
+
Z
m,c1,c0
E(Y |m, c1, e0, c0)Ot=0ft(M = m|c1, e, c0)f(C1 = c1|e0, c0)f(C0 = c0)d⌫(m, c1, c0)
(A.7)
+
Z
m,c1,c0
E(Y |m, c1, e0, c0)f(M = m|c1, e, c0)Ot=0ft(C1 = c1|e0, c0)f(C0 = c0)d⌫(m, c1, c0)
(A.8)
+
Z
m,c1,c0
E(Y |m, c1, e0, c0)f(M = m|c1, e, c0)f(C1 = c1|e0, c0)Ot=0ft(C0 = c0)d⌫(m, c1, c0),
(A.9)
where
(A.6) =
Z
m,c1,c0
Ot=0Et(Y |m, c1, e0, c0)f(M = m|c1, e, c0)f(C1 = c1|e0, c0)f(C0 = c0)
⇥ d⌫(m, c1, c0)
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=Z
m,c1,c0
Z
y
y
⇢Ot=0ft(y,m, c1, e0, c0)
f(m, c1, e0, c0)
  f(y,m, c1, e
0, c0)Ot=0ft(m, c1, e0, c0)
f(m, c1, e0, c0)2
 
d⌫(y)
⇥ f(M = m|c1, e, c0)f(C1 = c1|e0, c0)f(C0 = c0)d⌫(m, c1, c0)
=
Z
y,m,c1,c0
⇢
y
Ot=0ft(y,m, c1, e0, c0)
f(m, c1, e0, c0)
  Ot=0ft(m, c1, e
0, c0)
f(m, c1, e0, c0)
E(Y |m, c1, e0, c0)
⇥ f(y|m, c1, e0, c0)
 
f(M = m|c1, e, c0)f(C1 = c1|e0, c0)f(C0 = c0)d⌫(y,m, c1, c0)
=
Z
y,m,c1,e⇤,c0
⇢
y
Ot=0ft(y,m, c1, e⇤, c0)
f(m, c1, e0, c0)
  Ot=0ft(m, c1, e
⇤, c0)
f(m, c1, e0, c0)
E(Y |m, c1, e0, c0)
⇥ f(y|m, c1, e0, c0)
 
1e0(e
⇤)f(M = m|c1, e, c0)f(C1 = c1|e0, c0)f(C0 = c0)
⇥ d⌫(y,m, c1, e⇤, c0)
=E

1e0(E)f(M |C1, e0,C0)f(C1|e0,C0)f(C0)
f(Y,M,C1, E,C0)
⇥
⇢
Y
Ot=0ft(Y,M,C1, E,C0)
f(M,C1, e0,C0)
 f(Y |M,C1, e0,C0)Ot=0ft(M,C1, E,C0)
f(M,C1, e0,C0)
B(M,C1, e
0,C0)
  
=E

1e0(E)f(M |C1, e,C0)f(C1|e0,C0)f(C0)
f(Y,M,C1, E,C0)f(M,C1, e0,C0)
{Y Ot=0ft(Y,M,C1, E,C0)
  [Ot=0ft(Y,M,C1, E,C0)  f(M,C1, e0,C0)Ot=0ft(Y |M,C1, E,C0)]
⇥B(M,C1, e0,C0)}
 
=E
Ot=0ft(Y,M,C1, E,C0)
f(Y,M,C1, E,C0)
1e0(E)f(M |C1, e,C0)
f(M |C1, e0,C0)f(E = e0|C0){Y   B(M,C1, e
0,C0)}
 
+
Z
m,c1,c0
f(c1|e0, c0)f(m|c1, e, c0)f(c0)Ot=0
⇢Z
y
ft(y|m, c1, e0, c0)d⌫(y)
 
⇥ B(m, c1, e0, c0)d⌫(m, c1, c0)
=E

UO
1e0(E)f(M |C1, e,C0)
f(M |C1, e0,C0)f(E = e0|C0){Y   B(M,C1, e
0,C0)}
 
,
(A.7) =
Z
m,c1,c0
E(Y |m, c1, e0, c0)
⇢Ot=0ft(m, c1, e, c0)
f(c1, e, c0)
  Ot=0ft(c1, e, c0)f(m, c1, e, c0)
f(c1, e, c0)2
 
⇥ f(c1|e0, c0)f(c0)d⌫(m, c1, c0)
=
Z
m,c1,c0
E(Y |m, c1, e0, c0)Ot=0ft(m, c1, e, c0)
f(c1, e, c0)
f(c1|e0, c0)f(c0)d⌫(m, c1, c0)
 
Z
c1,c0
Ot=0ft(c1, e, c0)
f(c1, e, c0)
E(E(Y |m, c1, e0, c0)|c1, e, c0)f(c1|e0, c0)f(c0)d⌫(c1, c0)
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=Z
m,c1,c0
f(c1|e0, c0)f(c0)
f(c1, e, c0)
 
Ot=0ft(m, c1, e, c0)E(Y |m, c1, e0, c0)
  Ot=0ft(c1, e, c0)f(m|c1, e, c0)B0(c1, e0, e, c0)
 
d⌫(m, c1, c0)
=
Z
m,c1,c0
f(c1|e0, c0)
f(c1|e, c0)f(e|c0)
 
Ot=0ft(m, c1, e, c0)E(Y |m, c1, e0, c0)
  [Ot=0ft(m, c1, e, c0)  f(c1, e, c0)Ot=0ft(m|c1, e, c0)]B0(c1, e0, e, c0)
 
d⌫(m, c1, c0)
=
Z
m,c1,c0
Ot=0ft(m, c1, e, c0)
f(c1|e0, c0)
f(c1|e, c0)f(e|c0) {E(Y |m, c1, e
0, c0)  B0(c1, e0, e, c0)}
⇥ d⌫(m, c1, c0) +
Z
c1,c0
f(c1|e0, c0)f(c0)Ot=0
Z
m
ft(m|c1, e, c0)d⌫(m)B0(c1, e0, e, c0)
⇥ d⌫(c1, c0)
=
Z
m,c1,c0
⇢Z
y
f(y|m, c1, e, c0)d⌫(y)Ot=0ft(m, c1, e, c0)
+Ot=0
Z
y
ft(y|m, c1, e, c0)d⌫(y)f(m, c1, e, c0)
 
f(c1|e0, c0)
f(c1|e, c0)f(e|c0)
⇥ {E(Y |m, c1, e0, c0)  B0(c1, e0, e, c0)} d⌫(m, c1, c0)
=
Z
y,m,c1,c0
Ot=0ft(y,m, c1, e, c0)
f(c1|e0, c0)
f(c1|e, c0)f(e|c0)
⇥ {E(Y |m, c1, e0, c0)  B0(c1, e0, e, c0)} d⌫(y,m, c1, c0)
=
Z
y,m,c1,e⇤,c0
Ot=0ft(y,m, c1, e⇤, c0)
1e(e⇤)f(c1|e0, c0)
f(c1|e, c0)f(e|c0)
⇥ {E(Y |m, c1, e0, c0)  B0(c1, e0, e, c0)} d⌫(y,m, c1, e⇤, c0)
=E

UO
1e(E)f(C1|e0,C0)
f(C1|e,C0)f(e|C0) {E(Y |M,C1, e
0,C0)  B0(C1, e0, e,C0)}
 
,
(A.8) =
Z
m,c1,c0
E(Y |m, c1, e0, c0)f(m|c1, e, c0)
⇢Ot=0ft(c1, e0, c0)
f(e0, c0)
 Ot=0ft(e
0, c0)f(c1, e0, c0)
f(e0, c0)2
 
f(c0)d⌫(m, c1, c0)
=
Z
c1,c0
E(E(Y |M,C1, e0,C0)|c1, e, c0)
⇢Ot=0ft(c1, e0, c0)
f(e0, c0)
  Ot=0ft(e
0, c0)
f(e0, c0)
f(c1|e0, c0)
 
⇥ f(c0)d⌫(c1, c0)
=
Z
c1,c0
B0(c1, e0, e, c0)
Ot=0ft(c1, e0, c0)
f(e0, c0)
f(c0)d⌫(c1, c0)
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 
Z
c0
E(E(E(Y |M,C1, e0,C0)|C1, e,C0)|e0, c0)Ot=0ft(e
0, c0)
f(e0, c0)
f(c0)d⌫(c0)
=
Z
c1,c0
f(c0)
f(e0, c0)
{Ot=0ft(c1, e0, c0)B0(c1, e0, e, c0)
 Ot=0ft(e0, c0)f(c1|e0, c0)B00(e0, e, c0)} d⌫(c1, c0)
=
Z
c1,c0
1
f(e0|c0) {Ot=0ft(c1, e
0, c0)B0(c1, e0, e, c0)
  [Ot=0ft(c1, e0, c0)  Ot=0ft(c1|e0, c0)f(e0, c0)]B00(e0, e, c0)} d⌫(c1, c0)
=
Z
c1,c0
1
f(e0|c0)Ot=0ft(c1, e
0, c0) {B0(c1, e0, e, c0)  B00(e0, e, c0)} d⌫(c1, c0)
+
Z
c0
f(c0)Ot=0
Z
c1
ft(c1|e0, c0)d⌫(c1)B00(e0, e, c0)d⌫(c0)
=
Z
c1,c0
1
f(e0|c0)
8<:
Z
y,m
f(y,m|c1, e0, c0)d⌫(y,m)Ot=0ft(c1, e0, c0)
+Ot=0
Z
y,m
ft(y,m|c1, e0, c0)d⌫(y,m)f(c1, e0, c0)
9=; {B0(c1, e0, e, c0)  B00(e0, e, c0)}
⇥ d⌫(c1, c0)
=
Z
y,m,c1,c0
Ot=0ft(y,m, c1, e0, c0)
f(e0|c0) {B
0(c1, e0, e, c0)  B00(e0, e, c0)} d⌫(y,m, c1, c0)
=
Z
y,m,c1,e⇤,c0
Ot=0ft(y,m, c1, e⇤, c0)
1e0(e⇤)
f(e0|c0) {B
0(c1, e0, e, c0)  B00(e0, e, c0)}
⇥ d⌫(y,m, c1, e⇤, c0)
=E

UO
1e(E 0)
f(e0|C0) {B
0(c1, e0, e,C0)  B00(e0, e,C0)}
 
,
and
(A.9) =
Z
c0
E(E(E(Y |M,C1, e0,C0)|C1, e,C0)|e0,C0)Ot=0ft(c0)d⌫(c0)   0EUO
=
Z
c0
8<:
Z
y,m,c1,e⇤
f(y,m, c1, e
⇤|c0)d⌫(y,m, c1, e⇤)Ot=0ft(c0)
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+Ot=0
Z
y,m,c1,e⇤
ft(y,m, c1, e
⇤|c0)d⌫(y,m, c1, e⇤)f(c0)
9=;B00(e0, e, c0)d⌫(c0)  E[UO 0]
=
Z
y,m,c1,e⇤,c0
Ot=0ft(y,m, c1, e⇤, c0)B00(e0, e, c0)d⌫(y,m, c1, e⇤, c0)  E[UO 0]
=E [UO {B00(e0, e,C0)   0}] .
Thus, @ t@t
  
t=0
= E[UOV eff ( 0)] where
V eff ( 0) =
1e0(E)f(M |e,C1,C0)
f(M |e0,C1,C0)f(e0|C0) {Y   B(M,C1, e
0,C0)}
+
1e(E)f(C1|e0,C0)
f(C1|e,C0)f(e|C0) {B(M,C1, e
0,C0)  B0(C1, e0, e,C0)}
+
1e0(E)
f(e0|C0) {B
0(C1, e0, e,C0)  B00(e0, e,C0)}+ {B00(e0, e,C0)   0} ,
so if a RAL estimator exists, then V eff ( 0) is the corresponding influence function. It is efficient
because the modelMnonpar is nonparametric.
A.4 Multiple-Robustness of the Efficient Influence Function
Let B˜, ˜✓M = {M˜ ratio, E˜[B˜(M,C1, e0,C0)|C1, e,C0]}, ✓˜C1 = {C˜ratio1 , E˜[B˜0(C1, e, c0)|e0,C0]},
and f˜E|C0 denote limits of the estimators using the working models BW , ✓WM , ✓WC1 , and f
W
E|C0 . We
have established the following multiply-robust property of V eff :
TheoremA.2. The estimating equation V eff ( 0, B˜, ✓˜M, ✓˜C1 , f˜E|C0) is unbiased provided that one
of the following holds:
(a){✓˜M, f˜E|C0} = {✓M , fE|C0},
(b){B˜, ✓˜C1 , f˜E|C0} = {B,✓C1 , fE|C0}, or
(c){B˜, ✓˜C1 , ✓˜M} = {B,✓C1 ,✓M}.
Proof.
EV eff ( 0,B˜, ✓˜M, ✓˜C1 , f˜E|C0) =
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E24 Z
m,c1
M˜ ratio
f˜(e0|C0)
n
B(m, c1, e
0,C0)  B˜(m, c1, e0,C0)
o
⇥ f(m|c1, e0,C0)f(c1|e0,C0)f(e0|C0)d⌫(m, c1)
+
Z
c1
1
C˜ratio1 f˜(e|C0)
n
E
h
B˜(M, c1, e
0,C0)|c1, e,C0
i
  E˜
h
B˜(M, c1, e
0,C0)|c1, e,C0
io
⇥ f(c1|e,C0)f(e|C0)d⌫(c1)
+
f(e0|C0)
f˜(e0|C0)
n
E
h
E˜
h
B˜(M,C1, e
0,C0)|C1, e,C0
i
|e0,C0
i
 E˜
h
E˜
h
B˜(M,C1, e
0,C0)|C1, e,C0
i
|e0,C0
io
+E˜
h
E˜
h
B˜(M,C1, e
0,C0)|C1, e,C0
i
|e0,C0
i
 E [E [B(M,C1, e0,C0)|C1, e,C0] |e0,C0]
35
Substituting under (a):
EV eff ( 0,B˜, ✓˜M, ✓˜C1 , f˜E|C0) =
E
24 Z
m,c1
n
B(m, c1, e
0,C0)  B˜(m, c1, e0,C0)
o
f(m|c1, e,C0)f(c1|e0,C0)d⌫(m, c1)
+
n
E
h
E
h
B˜(M,C1, e
0,C0)|C1, e,C0
i
|e0,C0
i
  E˜
h
E
h
B˜(M,C1, e
0,C0)|C1, e,C0
i
|e0,C0
io
+E˜
h
E
h
B˜(M,C1, e
0,C0)|C1, e,C0
i
|e0,C0
i
 E [E [B(M,C1, e0,C0)|C1, e,C0] |e0,C0]
35
= 0
Substituting under (b):
EV eff ( 0,B˜, ✓˜M, ✓˜C1 , f˜E|C0) =Z
c1
n
E [B(M, c1, e0,C0)|c1, e,C0]  E˜ [B(M, c1, e0,C0)|c1, e,C0]
o
f(c1|e0,C0)d⌫(c1)
+E
h
E˜ [B(M,C1, e0,C0)|C1, e,C0] |e0,C0
i
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 E [E [B(M,C1, e0,C0)|C1, e,C0] |e0,C0]
35
= 0
Substituting under (c):
EV eff ( 0, B˜, ✓˜M, ✓˜C1 , f˜E|C0) = 0, trivially.
Thus,  ˆmr can be shown to be asymptotically normal under each of these scenarios using a
Taylor expansion of PnV eff ( ˆmr, Bˆ, ✓ˆM, ✓ˆC1 , fˆE|C0) and applying the central limit theorem to
n 1/2
P
i V
eff
i ( 0, B
⇤,✓⇤M ,✓
⇤
C1 , f
⇤
E|C0).
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Appendix B
Additional stabilization technique for the
multiply-robust estimator
This technique is an adaptation of the approach presented by Robins et al. (2007). The idea is
to carefully select regression models and an estimation strategy such that the three terms in  ˆmr
depending on weights are empirically evaluated as null, leaving the term Bˆ00(e0, e,C0), which does
not depend on weights. This can be accomplished with the following steps. First, fit propensity
score models to estimate fE|C0 , M ratio, and Cratio1 . Substitute these estimates into the first term
of  ˆmr, and include the result in a set of estimating equation to solve for the Y -regression-model
parameters. Next, plug in all parameters estimated thus far into the second term of  ˆmr, and once
again use the result in a set of estimating equations to solve for the M -regression-model parame-
ters. Repeat this step with the third term of  ˆmr to solve for the C1-regression-model parameters.
Finally, plugging all of these parameter estimates into  ˆmr leaves Bˆ00(e0, e,C0), as desired. If Y ,
M , and C1 are all scalar, continuous random variables, this procedure is equivalent to repeatedly
fitting regression models with intercepts using weighted least squares with appropriately-chosen
weights.
Appendix C
Plots comparing estimators in the PEPFAR
Nigeria study
Figure C.1: PEMY -specific effects on virologic failure. The plot in each cell represents estimates
for the effect with comparison-level treatment, e, equal to the first index of the cell and baseline-
level treatment, e0 equal to the second index of the cell. That is, comparison level treatment varies
across rows and baseline level treatment varies across columns. Within each plot, the dots and
vertical bars represent point estimates using the four estimators and their corresponding bootstrap
confidence intervals.
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Figure C.1: (Continued)
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Figure C.2: PEMY -specific effects on CD4 count. The plot in each cell represents estimates for
the effect with comparison-level treatment, e, equal to the first index of the cell and baseline-level
treatment, e0 equal to the second index of the cell. That is, comparison level treatment varies
across rows and baseline level treatment varies across columns. Within each plot, the dots and
vertical bars represent point estimates using the four estimators and their corresponding bootstrap
confidence intervals.
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Figure C.2: (Continued)
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Appendix D
Proofs for Chapter 2
Proof of Theorem 2.1. For each level m and y, define ⇡1(m, y) = pr{Y (a,m) = y} and
⇡2(m) = pr{M(a⇤) = m}. There exist U1(m, y), U2(m) ⇠ U(0, 1) such that I{Y (a,m) =
y} = I{U1(m, y)  ⇡1(m, y)} and I{M(a⇤) = m} = I{U2(m)  ⇡2(m)}. The joint distribu-
tion FU1(m,y),U2(m), then, is a bivariate copula, for which Fréchet–Hoeffding sharp bounds exist.
Applying these to pr {Y (a,m) = y,M(a⇤) = m} = FU1(m,y),U2(m) {⇡1(m, y), ⇡2(m)}, we have
max [0, pr{M(a⇤) = m}+ pr{Y (a,m) = y}  1]
 pr {Y (a,m) = y,M(a⇤) = m} 
min [pr{M(a⇤) = m}, pr{Y (a,m) = y}] .
Applying these bounds to each summand in
E[Y {a,M(a⇤)}] =
X
m,y
ypr{Y (a,m) = y,M(a⇤) = m}
yields the result.
Proof of Theorem 2.3. Let ⇡r,r⇤ = pr {R(a) = r, R(a⇤) = r⇤}, ⇡ be the vectorization of the matrix
[⇡r,r⇤ ], and   be the vectorization of the matrix [⇡r,r⇤ ] p, p, i.e., the vectorization of the matrix ⇡
with row p and column p removed. Equation (2.1) can now be expressed as  0 = xT⇡, which is
identified in x, but not ⇡. Conditional on the marginal probabilities, which are identified, the joint
probabilities have (p  1)2 degrees of freedom, and can be expressed as ⇡ = B  + d. Since xTB 
is linear in   and each element of   is constrained by
max {0, pr(R = r | A = a) + pr(R = r⇤ | A = a⇤)  1}
 ⇡r,r⇤ 
min {pr(R = r | A = a), pr(R = r⇤ | A = a⇤)} ,
the proposed linear programming problem will yield the   that optimizes xTB , and hence
xT (B  + d). Thus,  0 will be bounded by xT (B  + d) evaluated at the minimizing and maxi-
mizing linear programming solutions  L and  U .
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Appendix E
Proofs and additional figures for Chapter 3
Proof of Theorem 3.1. Let ↵¯ be the true value of ↵. UnderMA,
E{U(↵¯)} =E[{`(C)Y +m(C)}(A  E(A | C,X⇤)  ↵¯T2 "⇤)]
=E[{`(C)Y +m(C)}A]  E[E{`(C)Y +m(C) | C,X⇤}E(A | C,X⇤)]
  ↵T2E["⇤]E[{`(C)Y +m(C)}]
=E[{`(C)Y +m(C)}A]  E {E (E[{`(C)Y +m(C)}A | A,C,X⇤] | C,X⇤)}
=0,
since Y ?? ✏⇤, C ?? ✏⇤, and E(Y | A,C,X⇤) = E(Y | C,X⇤), which is implied by H0 and
Assumption 1. The regularity conditions on U(↵) are sufficient to ensure that ↵¯ is a local minimum
of nUˆn(↵)T ⌦ˆ 1n Uˆn(↵), and hence ↵ is locally identified under H0. Then because dim[U(↵)] =
dim(↵) + q, E{U(↵)} = 0 is an overidentified moment restriction, and the statistic  2robustA has a
limiting distribution of  2q .
Proof of Theorem 3.2. Let  ¯ and ↵¯2 be the true values of   and ↵2 respectively. Under MY ,
E{S( ¯)} = 0 and
E
⇥
k(C) {Y   gY (C;  ¯)}
 
A  ↵¯T2X
 ⇤
=E
⇥
k(C) {Y   E (Y | C)} A  E(A | C,X⇤) + E(A | C,X⇤ = 0)  ↵¯T2 "⇤ ⇤
=E [k(C) {Y   E (Y | C)}A]  E [k(C)E {Y   E (Y | C) | C,X⇤}E(A | C,X⇤)]
+ E
⇥
k(C)E {Y   E(Y | C) | C} E(A | C,X⇤ = 0)  ↵¯T2E("⇤) ⇤
=E [k(C) {Y   E (Y | C)}A]  E {k(C)E (E[{Y   E (Y | C)}A | A,C,X⇤] | C,X⇤)}
=0,
since Y ?? ✏⇤, C ?? ✏⇤, and E(Y | A,C,X⇤) = E(Y | C,X⇤), which is implied by H0 and
Assumption 1. The regularity conditions on U(↵,  ) are sufficient to ensure that (↵¯2,  ¯) is a lo-
cal minimum of nUˆn(↵,  )T ⌦ˆ 1n Uˆn(↵,  ), and hence (↵2,  ) is locally identified under H0. Then
because dim[U(↵,  )] = dim(↵2) + dim( ) + q, E{U(↵,  )} = 0 is an overidentified moment
restriction, and the statistic  2robustY has a limiting distribution of  
2
q .
Proof of Theorem 3.3. Let  ¯ be the true value of   underMY and ↵¯ be the true value of ↵ under
MA. UnderMA, there exists some  ˜ such that E{S( ˜)} = 0. That
E

k(C) Y ( ˜) A(↵¯)
{`(C)Y +m(C)} A(↵¯)
 
= 0
follows from the unbiasedness of U(↵) shown in the proof of Theorem 3.1.
UnderMY , E{S( ¯)} = 0 and for any ↵1,
E
⇥
k(C) {Y   gY (C;  ¯)}
 
A  gA(C;↵1)  ↵¯T2X
 ⇤
=E
⇥
k(C) {Y   E (Y | C)} A  E(A | C,X⇤) + E(A | C,X⇤ = 0)  gA(C;↵1)  ↵¯T2 "⇤ ⇤
=E [k(C) {Y   E (Y | C)}A]  E [k(C)E {Y   E (Y | C) | C,X⇤}E(A | C,X⇤)]
+ E
⇥
k(C)E {Y   E(Y | C) | C} E(A | C,X⇤ = 0)  gA(C;↵1)  ↵¯T2E("⇤) ⇤
=E [k(C) {Y   E (Y | C)}A]  E {k(C)E (E[{Y   E (Y | C)}A | A,C,X⇤] | C,X⇤)}
=0,
since Y ?? ✏⇤, C ?? ✏⇤, and E(Y | A,C,X⇤) = E(Y | C,X⇤), which is implied by H0 and
Assumption 1. Finally, there exists some ↵˜1 such that
E [{`(C)Y +m(C)} A(↵˜1, ↵¯2)] = 0.
Thus, under any law inM[, E{U(↵,  )} = 0 has a solution under H0. The regularity condi-
tions on U(↵,  ) are sufficient to ensure that (↵¯,  ¯) is a local minimum of nUˆn(↵,  )T ⌦ˆ 1n Uˆn(↵,  ),
and hence (↵,  ) is locally identified under H0. Then because dim[U(↵,  )] = dim(↵)+dim( )+q,
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E{U(↵,  )} = 0 is an overidentified moment restriction, and the statistic  2dr has a limiting distri-
bution of  2q .
Proof of Theorem 3.4. First, reparameterize the propensity-score model as
logit Pr(A = 1 | C,X⇤) = ↵0 + g(C;↵1) + ↵T2X⇤,
for binary A or
logE(A | C,X⇤) = ↵0 + g(C;↵1) + ↵T2X⇤,
for count A, where g(0;↵1) = 0, such that ↵0 is a scalar intercept and ↵1 has dimension p1   1.
When A is binary, for the true value ↵¯ of ↵, we have
E
 {`(C)Y +m(C)} exp   ↵¯T2XA  [A  expit (↵⇤0 + g(C; ↵¯1))] 
= E
 {`(C)Y +m(C)} exp   ↵¯T2X⇤A  ↵¯T2 "⇤A  [A  expit (↵⇤0 + g(C; ↵¯1))] 
= E
 {`(C)Y +m(C)} exp   ↵¯T2X⇤A E  exp   ↵¯T2 "⇤A  |A, Y, C,X⇤ 
⇥ [A  expit (↵⇤0 + g(C; ↵¯1))]}
= E
 {`(C)Y +m(C)} exp   ↵¯T2X⇤A  exp (KA) [A  expit (↵⇤0 + g(C; ↵¯1))] 
where exp (K) = E
 
exp
  ↵¯T2 "⇤   is the moment generating function of "⇤ evaluated at  ↵¯2.
We then note that the joint density of (A,X⇤) given C can be expressed as
f (A,X⇤|C) = f (X
⇤|A = 0, C) exp  ↵¯T2X⇤A  f (A|X⇤ = 0, C)
t(C)
where t(C) is a normalizing constant. We then have that
E
 {`(C)Y +m(C)} exp   ↵¯T2X⇤A  exp (KA) [A  expit (↵⇤0 + g(C; ↵¯1))] 
= E
Z
x
X
a
f (x|A = 0, C) exp  ↵¯T2 xa  f (a|X = 0, C)
t(C)
⇥ [`(C)E {Y | a, x, C}+m(C)] exp   ↵¯T2 xa  exp (Ka) [a  expit (↵⇤0 + g(C; ↵¯1))] dx
= E
Z
x
[`(C)E {Y | x, C}+m(C)] f (x|A = 0, C) t(C) 1dx
⇥
X
a
f (a|X = 0, C) exp (Ka) [a  expit (↵⇤0 + g(C; ↵¯1))]
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= E
Z
x
[`(C)E {Y | x, C}+m(C)] f (x|A = 0, C) t(C) 1dx1 + exp (↵
⇤
0 + g(C; ↵¯1))
1 + exp (↵¯0 + g(C; ↵¯1))
⇥
X
a
exp (↵⇤0a+ g(C; ↵¯1)a)
1 + exp (↵⇤0 + g(C; ↵¯1))
[a  expit (↵⇤0 + g(C; ↵¯1))]
= 0
where ↵⇤0 = K + ↵¯0.
When A is a count, let exp(K) = E
 
exp(↵¯T2 "
⇤)
 
, i.e., the moment generating function of "⇤
evaluated at ↵¯2. For the true value ↵¯ of ↵, we have
E
 
Y
⇥
A  exp ↵⇤0 + g(C; ↵¯1) + ↵¯T2X ⇤ 
=E(Y A)  E ⇥Y exp ↵⇤0 + g(C; ↵¯1) + ↵¯T2X⇤ E  exp(↵¯T2 "⇤) ⇤
=E(Y A)  E ⇥Y exp ↵¯0 + g(C; ↵¯1) + ↵¯T2X⇤ ⇤
=E(Y A)  E {E(Y | C,X⇤)E(A | C,X⇤)}
=E(Y A)  E [E {E(Y A | A,C,X⇤) | C,X⇤}]
=0,
where ↵⇤0 = K + ↵¯0.
Thus, in either case, E{U(↵⇤0, ↵¯1, ↵¯2)} = 0 under H0. The regularity conditions on U(↵)
are sufficient to ensure that (↵⇤0, ↵¯1, ↵¯2) is a local minimum of nUˆn(↵)T ⌦ˆ 1n Uˆn(↵), and hence ↵
is locally identified under H0. Then because dim[U(↵)] = dim(↵) + q, E{U(↵)} = 0 is an
overidentified moment restriction, and the statistic  2robustA has a limiting distribution of  
2
q .
Theorem E.1. Let  ˆ(`,m) be the estimator solving PnU(`,m;  ) = 0 corresponding to the mo-
ment functions in Theorem 3.1, and
d(C) ⌘ E{ (↵)2H( )2 | C}E{ (↵)2 | C}  E{ (↵)2H( ) | C}E{ (↵)2H( ) | C}.
For
`⇤(C) = d(C) 1
2664
E { (↵)2 | C}E { (↵)A | C}
 Cov{ (↵)2, H( ) | C}
E { (↵)2 | C}E { (↵)A | C} {r↵Cg(C;↵C)}T
E(H( )X | C)E { (↵)2 | C}  E(X | C)E { (↵)2H( ) | C}
3775
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and
m⇤(C) = d(C) 1
2664
 E { (↵)2H( ) | C}E { (↵)A | C}
 Cov{ (↵)2H( ), H( ) | C}
 E { (↵)2H( ) | C}E { (↵)A | C} {r↵Cg(C;↵C)}T
E(H( )X | C)E { (↵)2H( ) | C}  E(X | C)E { (↵)2H( )2 | C}
3775 ,
 ˆ(`⇤,m⇤) achieves the minimum asymptotic variance of all estimators in the class
of estimators defined by these estimating equations. The corresponding variance is
E
⇥
U(`⇤,m⇤;  )U(`⇤,m⇤;  )T
⇤
.
Proof. By Theorem 5.3 in Newey and McFadden (1994), if an optimal estimator  ˆ(˜`, m˜) exists
within the class { ˆ(`,m) : ` 2 L,m 2M}, the functions ˜`and m˜ are guaranteed to satisfy
 E

@
@ 
U(`,m;  )
 
= E
h
U(`,m;  )U(˜`, m˜;  )T
i
(E.1)
for all functions ` andm, and the estimator will have variance equal to E
h
U(˜`, m˜;  )U(˜`, m˜;  )T
i
.
Thus it suffices to show that `⇤(C) andm⇤(C) satisfy (E.1). We have
 E

@
@ 
U(`,m;  )
 
= E [`(C)A (↵), `(C)H( ) +m(C),
{`(C)H( ) +m(C)}{r↵Cg(C;↵C)}T , {`(C)H( ) +m(C)}XT
⇤
= E
⇢
[`(C),m(C)]

V
W
  
,
where V = [V1, V2, V3, V4] ⌘ [A (↵), H( ), H( ){r↵Cg(C;↵C)}T , H( )XT ] and W =
[W1,W2,W3,W4] ⌘ [0, 1, {r↵Cg(C;↵C)}T , XT ]. If we partition the components of the func-
tions (`⇤,m⇤) into (`⇤1,m⇤1), (`⇤2,m⇤2), (`⇤3,m⇤3), and (`⇤4,m⇤4), where `⇤1, m⇤1, `⇤2, and m⇤2 are scalar
functions, `⇤3 andm⇤3 are p1 dimensional, and `⇤4 andm⇤4 are p2 dimensional, then
E
⇥
U(`,m;  )U(`⇤,m⇤;  )T
⇤
= E
⇥
 (↵)2{`(C)H( ) +m(C)}{`⇤(C)H( ) +m⇤(C)}T ⇤
=E
⇥
 (↵)2{`(C)H( ) +m(C)} ⇥`⇤1(C)H( ) +m⇤1(C), {`⇤2(C)H( ) +m⇤2(C)}T ,
{`⇤3(C)H( ) +m⇤3(C)}T , `⇤4(C)H( ) +m⇤4(C)
⇤⇤
.
Thus, we can solve (E.1) by partitioning it into four independent equations corresponding to
the partition of `⇤ andm⇤, i.e., for k = 1, 2, 3, 4,
E
⇥
 (↵)2{`(C)H( ) +m(C)} {`⇤k(C)H( ) +m⇤k(C)}
⇤
= E {`(C)Vk +m(C)Wk} .
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E
⇥
E
⇥
 (↵)2 {`⇤k(C)H( ) +m⇤k(C)}H( ) | C
⇤
`(C)
 E ⇥ (↵)2 {`⇤k(C)H( ) +m⇤k(C)} | C⇤m(C)⇤ = E {`(C)Vk +m(C)Wk}
,
E
⇥
E
⇥
 (↵)2 {`⇤k(C)H( ) +m⇤k(C)}H( )  Vk | C
⇤
`(C)
 E ⇥ (↵)2 {`⇤k(C)H( ) +m⇤k(C)} Wk | C⇤m(C)⇤ = 0
,
E[ (↵)2H( )2 | C]`⇤k(C) + E[ (↵)2H( ) | C]m⇤k(C)  E(Vk | C) = 0
E[ (↵)2H( ) | C]`⇤k(C) + E[ (↵)2 | C]m⇤k(C)  E(Wk | C) = 0
, 
`⇤k(C)
m⇤k(C)
 
=

E{ (↵)2H( )2 | C} E{ (↵)2H( ) | C}
E{ (↵)2H( ) | C} E{ (↵)2 | C}
  1 
E(Vk | C)
E(Wk | C)
 
given that Pr{d(C) 6= 0} = 1 The second implication can be seen to hold by recognizing the
necessity of the first equation when `(C) = E [ (↵)2 {`⇤k(C)H( ) +m⇤k(C)}H( )  Vk | C]
and b(C) = 0 and the necessity of the second equation when `(C) = 0 and b(C) =
E [ (↵)2 {`⇤k(C)H( ) +m⇤k(C)} Wk | C]. Thus, (E.1) is solved by
`⇤1(C) = E
 
 (↵)2 | C E { (↵)A | C} d(C) 1
m⇤1(C) =  E
 
 (↵)2H( ) | C E { (↵)A | C} d(C) 1
`⇤2(C) =  Cov{ (↵)2, H( ) | C}d(C) 1
m⇤2(C) =  Cov{ (↵)2H( ), H( ) | C}d(C) 1
`⇤3(C) = `
⇤
1(C){r↵Cg(C;↵C)}T
m⇤3(C) = m
⇤
1(C){r↵Cg(C;↵C)}T
`⇤4(C) =
⇥
E(H( )X | C)E   (↵)2 | C   E(X | C)E   (↵)2H( ) | C ⇤ d(C) 1
m⇤4(C) =
⇥
E(H( )X | C)E   (↵)2H( ) | C   E(X | C)E   (↵)2H( )2 | C ⇤ d(C) 1.
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Figure E.1: Power simulation results for n=1000.
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Figure E.1: (Continued)
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Figure E.2: Power simulation results for n=10,000.
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Figure E.2: (Continued)
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